What are Datasets?
Datasets are defined file collections, whose access is governed by a Data Access Committee (DAC).
Total number of Datasets: 3997
Displaying 1 - 3997
| Dataset Accession | Description | Technology |
Samples |
File Types |
|---|---|---|---|---|
| EGAD00000000019 | 840 families where both parents have been genotyped together with the child with severe malaria | 0 | ||
| EGAD00000000020 | 685 families where both parents have been genotyped together with the child with severe malaria | 0 | ||
| EGAD00000000017 | Cord blood control samples from Gambia | 0 | ||
| EGAD00000000018 | Severe malaria cases from Gambia | 0 | ||
| EGAD00010000702 | SNP-chip genotyping data for one proband in the DDD study (Ref : Carvalho AJHG 2015) | 0 | ||
| EGAD00010000534 | Illumina HumanMethylation450 BeadChip | 0 | ||
| EGAD00010000528 | Illumina HumanHT-12 v4 array | 0 | ||
| EGAD00010000532 | Illumina Human Omni1-Quad SNP genotyping array | 0 | ||
| EGAD00010000556 | SNP 6.0 arrays of small cell lung cancer | 0 | ||
| EGAD00010000568 | HipSci - Healthy Normals - Methylation Array - May 2014 | 0 | ||
| EGAD00010000698 | PCGP INF ALL SNP6 | 0 | ||
| EGAD00010000682 | glioma samples tumor using 250K | 0 | ||
| EGAD00010000688 | glioma normal samples using 250K | 0 | ||
| EGAD00010000684 | glioma normal samples using cytoscan | 0 | ||
| EGAD00010000686 | glioma samples tumor using cytoscan | 0 | ||
| EGAD00010000708 | Human samples typed on Illumina Omni 5M | 0 | ||
| EGAD00010000658 | DLBCL 148 SNP 6.0 Cohort | 0 | ||
| EGAD00010000612 | Celiac disease North Indian samples using Immunochip | 0 | ||
| EGAD00010000624 | A new beta-globin mutation responsible of a beta-thalassemia (HbVar database ID 2928) was observed in 8 unrelated French families. The mutation carriers originated from Nord-Pas-de-Calais, a Northern French region where the chief town is Lille. 5 unrelated mutation carriers were genotyped for a set of 12 microsatellites from chromosome 11, around the beta-globin gene. Among the 5 mutation carriers, 4 were genotyped for 97 European Ancestry Informative SNPs (EAIMs). | 0 | ||
| EGAD00010000648 | nccRCC tumor/normal genotypes | 0 | ||
| EGAD00010000656 | Case samples using SNP 6.0 Array | 0 | ||
| EGAD00010000654 | Control samples using SNP 6.0 Arrays | 0 | ||
| EGAD00010000771 | HipSci - Healthy Normals - Methylation Array - April 2015 | 0 | ||
| EGAD00010000696 | PCGP ETP ALL SNP6 | 0 | ||
| EGAD00010000724 | Pilot experiment on functional genomics in osteoarthritis (methyl) | 0 | ||
| EGAD00010000764 | Ovarian tumor samples using Illumina | 0 | ||
| EGAD00010000768 | Replication data for HipSci normal samples using both HumanCoreExome-12_v1 and HumanOmni2.5-8 BeadChips | 0 | ||
| EGAD00010000819 | Summary statistics from meta-analysis for BP phenotypes | 0 | ||
| EGAD00010000777 | HipSci - Bardet-Biedl Syndrome - Genotyping Array - November 2014 | 0 | ||
| EGAD00010000781 | HipSci - Bardet-Biedl Syndrome - Methylation Array - April 2015 | 0 | ||
| EGAD00010000817 | HipSci - Monogenic Diabetes - Methylation Array - April 2015 | 0 | ||
| EGAD00010000783 | HipSci - Bardet-Biedl Syndrome - Expression Array - November 2014 | 0 | ||
| EGAD00010000785 | HipSci - Monogenic Diabetes - Expression Array - November 2014 | 0 | ||
| EGAD00010001074 | Rare CNVs from schizophrenia cases and controls | Mulitple CNV platforms | 0 | |
| EGAD00010001141 | Summary data from Meta-analysis of Genome-Wide-Association Studies for plasma levels of Coagulation Factor XI (FXI) | 0 | ||
| EGAD00010001029 | Summary statistics for a multi-cohort epigenome-wide association study. This includes summary statistics (effect-size, standard error, p-value) for 470,000 methylation markers. | 0 | ||
| EGAD00010001184 | This data set includes the following summary level data file used for the imputation data: imputation.sv.assoc.txt: results from single variant association analysis in imputed samples | 0 | ||
| EGAD00010001185 | This data set includes the following summary level data files used for the GoT2D WGS analysis: wgs.assoc.samples.list: list of samples to keep for association analysis wgs.assoc.variants.list: list of variants to keep for association analysis wgs.sv.assoc.txt: single variant association results | 0 | ||
| EGAD00010001188 | This data set includes the following summary level data files used for the 13k analysis of T2D-GENES data: wes.variants.list: list of variants to keep for any analysis of the exomes data wes.assoc.samples.list: list of samples to keep for association analysis wes.assoc.variants.list: list of variants to keep for association analysis wes.sv.assoc.txt: single variant association analysis results wes.gene.ptv.variants.list.txt: list of protein truncating variants to use in gene-level analysis wes.gene.ptv.assoc.txt: results from gene-level tests of protein truncating variants wes.gene.nsstrict.variants.list.txt: list of NSstrict variants to use in gene-level analysis wes.gene.nsstrict.assoc.txt: results from gene-level tests of NSstrict variants wes.gene.nsbroad.variants.list.txt: list of NSbroad variants to use in gene-level analysis wes.gene.nsbroad.assoc.txt: results from gene-level tests of NSbroad variants wes.gene.ns.variants.list.txt: list of non synonymous variants to use in gene-level analysis wes.gene.ns.assoc.txt: results from gene-level tests of non synonymous variants | 0 | ||
| EGAD00010001187 | This data set includes the following summary level data file used for the exome chip analysis: exome_chip.sv.assoc.txt: results from single variant association analysis in exome chip | 0 | ||
| EGAD00010001296 | DNA methylation analysis from primary human JMML and normal blood samples using 450K | Illumina_450K | 0 | |
| EGAD00010001328 | HipSci - Healthy Normals - Genotyping Array - July 2017 | Illumina | 0 | |
| EGAD00000000024 | WTCCC2 project samples from National Blood Donors (NBS) Cohort | 1 | ||
| EGAD00001000081 | Splenic Marginal Zone Lymphoma with villous lymphocytes exome sequencing | Illumina HiSeq 2000 | 1 | bam |
| EGAD00000000023 | WTCCC2 project samples from National Blood Donors (NBS) Cohort | 1 | ||
| EGAD00000000053 | Sequencing data from Breast Cancer samples | Illumina Genome Analyzer II | 1 | |
| EGAD00000000054 | NCI-H209 is an immortal cell line derived from a bone marrow metastasis of a patient with small cell lung cancer, taken before chemotherapy. The specimen showed histologically typical small cells with classic neuroendocrine features. NCI-BL209 is an EBV-transformed B-cell line derived from the same patient as the small cell lung cancer cell line, NCI-H209 | Life Tech - Solid | 1 | |
| EGAD00010000823 | Results of SNP arrays on synchronous CRC samples | 1 | ||
| EGAD00000000104 | Gabriel samples from the Russian UFA cohort | unknown | 1 | |
| EGAD00000000098 | Gabriel samples from the Swiss SALPADIA cohort | unknown | 1 | |
| EGAD00000000090 | Gabriel samples from the Russian KMSU cohort | unknown | 1 | |
| EGAD00000000105 | Gabriel samples from the multicenter occupational cohort | unknown | 1 | |
| EGAD00000000087 | Gabriel samples from the multicenter GAIN cohort | unknown | 1 | |
| EGAD00000000092 | Gabriel samples from the German MAGIS cohort | unknown | 1 | |
| EGAD00000000083 | Gabriel samples from the French EGEA Cohort | unknown | 1 | |
| EGAD00000000088 | Gabriel samples from the Karelia Allergy Study | unknown | 1 | |
| EGAD00000000076 | Gabriel samples from the Australian Bussleton Cohort | unknown | 1 | |
| EGAD00000000095 | Gabriel samples from the Dutch PIAMA cohort | unknown | 1 | |
| EGAD00000000093 | Gabriel samples from the German MAGIS cohort | unknown | 1 | |
| EGAD00000000082 | Gabriel samples from the French EGEA Cohort | unknown | 1 | |
| EGAD00000000102 | Gabriel samples from the Russian TOMSK cohort | unknown | 1 | |
| EGAD00000000106 | Gabriel samples from the multicenter occupational cohort | unknown | 1 | |
| EGAD00000000085 | Gabriel samples from the German Gabriel Advanced Survey | unknown | 1 | |
| EGAD00000000108 | Gabriel samples from the UK AUGOSA cohort | unknown | 1 | |
| EGAD00000000075 | Gabriel samples from the Swedish BAMSE Cohort | unknown | 1 | |
| EGAD00000000107 | Gabriel samples from the multicenter occupational cohort | unknown | 1 | |
| EGAD00000000091 | Gabriel samples from the Russian KMSU cohort | unknown | 1 | |
| EGAD00000000101 | Gabriel samples from the Russian TOMSK cohort | unknown | 1 | |
| EGAD00000000074 | Gabriel samples from the Swedish BAMSE Cohort | unknown | 1 | |
| EGAD00000000103 | Gabriel samples from the Russian UFA cohort | unknown | 1 | |
| EGAD00000000086 | Gabriel samples from the multicenter GAIN cohort | unknown | 1 | |
| EGAD00000000077 | Gabriel samples from the Australian Bussleton Cohort | unknown | 1 | |
| EGAD00000000097 | Gabriel samples from the Swiss SALPADIA cohort | unknown | 1 | |
| EGAD00000000073 | Gabriel samples from the 1958 British Birth Cohort | unknown | 1 | |
| EGAD00000000084 | Gabriel samples from the German Gabriel Advanced Survey | unknown | 1 | |
| EGAD00000000089 | Gabriel samples from the Karelia Allergy Study | unknown | 1 | |
| EGAD00000000094 | Gabriel samples from the UK MRCA cohort | unknown | 1 | |
| EGAD00000000109 | Gabriel samples from the UK SEVERE cohort | unknown | 1 | |
| EGAD00000000096 | Gabriel samples from the Dutch PIAMA cohort | unknown | 1 | |
| EGAD00000000114 | Whole transcriptome sequence data from 18 ovarian clear-cell carcinoma samples and one TOV21G ovarian clear-cell carcinoma cell line | Illumina Genome Analyzer II | 1 | |
| EGAD00001000249 | This is the bam file generated after alignment using BWA program for the SAIF genome | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001000254 | This dataset contain the raw files generated for SAIF genome project | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000602 | Illumina HiSeq 2000; | 1 | bam | |
| EGAD00001000091 | Non Tumour Renal Cell Line Sequencing | Illumina Genome Analyzer II | 1 | bam |
| EGAD00001000308 | Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing | 1 | bam | |
| EGAD00000000031 | HLA genotyping of 1958 British Birth Cohort samples | unknown | 1 | |
| EGAD00001000139 | Tumor sample of a serious ovarian carcinoma | Complete Genomics | 1 | CompleteGenomics_native |
| EGAD00001000140 | Blood sample of serious ovarian carcinoma patient | Complete Genomics | 1 | CompleteGenomics_native |
| EGAD00000000045 | Genomic sequencing and transcriptome shotgun sequencing of a metastatic tumour and its recurrence after drug therapy in a single patient | Illumina Genome Analyzer II | 1 | |
| EGAD00000000048 | Sequencing data from oestrogen-receptor-alpha-positive metastatic lobular breast cancer sample | Illumina Genome Analyzer II | 1 | |
| EGAD00000000049 | RNA-SEQ data from oestrogen-receptor-alpha-positive metastatic lobular breast cancer sample | Illumina Genome Analyzer II | 1 | |
| EGAD00010000300 | Summary statistics from Haemgen RBC GWAS | Illumina, Affymetrix, Perlegen | 1 | |
| EGAD00001000301 | A couple of previously characterized and sequenced libraries will be repeated using a couple of differing size selection criteria and skim sequenced using an Illumina HiSeq. The resulting sequence will be analyzed to determine the optimal DNA library size for our specific downstream analysis. | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001000395 | Noninvasive Prenatal Molecular Karyotyping from Maternal Plasma | 1 | bam | |
| EGAD00001000601 | Illumina HiSeq 2000; | 1 | bam | |
| EGAD00010000482 | ccRCC case samples using methylation array | Illumina Infinium HumanMethylation 450K - GenomeStudio | 1 | |
| EGAD00001001285 | McGill EMC Release 4 in tissue "Brodmann (1909) area 44" | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001000665 | Illumina HiSeq sequence data (with >30x coverage) were aligned to the hg19 human reference genome assembly using BWA (Li and Durbin, 2009); duplicate reads were removed from the final BAM file. No realignment or recalibration was performed. Sample derived from secondary myelodysplastic syndrome (MDS), arising after treatment for medulloblastoma in an 11-year old female Li-Fraumeni syndrome case (LFS-MB1; Rausch et al., 2012; matching WGS data available under EGAS00001000085). | 1 | bam | |
| EGAD00001001277 | McGill EMC Release 4 in tissue "fat pad" for cell type "fat cell" | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001002238 | ChIP-Seq (H3K4me3, H3K4me1, H3K9me3, H3K27ac, H3K27me3, H3K36me3, Input) data for HL60 cell line generated at Centre for Epigenome Mapping Technologies, Genome Sciences Center, B.C. Cancer Agency. | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001000856 | Illumina HiSeq 2000; | 1 | fastq | |
| EGAD00001000756 | UK10K_OBESITY_SCOOP UK10K_EXOME_EXTRAS | Illumina HiSeq 2000; | 1 | tabix,vcf |
| EGAD00001000786 | We are interested in the contribution mutations in the Shelterin complex protein POT1 may have to the development of melanoma. We have identified a patient who carries a splice site mutation in POT1 and as part of our analysis of this gene we aim to sequence the transcriptome of this patient to see how this mutation influences splicing. RNA has been obtained from lymphocytes collected from the patient. | Illumina MiSeq; | 1 | cram |
| EGAD00010001332 | HipSci - Bardet-Biedl Syndrome - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00001000824 | RNA sequencing will be undertaken to reconstruct rearrangements at level of transcription to determine pathogenomic genomic events in chondromyxoid fibroma. | Illumina HiSeq 2000; | 1 | cram |
| EGAD00001000804 | UK10K_RARE_NMWG REL-2013-03-06 | Illumina HiSeq 2000; | 1 | tabix,vcf |
| EGAD00001000937 | RNA-Seq data for 1 alternatively activated macrophage sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000912 | RNA-Seq data for 1 CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000933 | RNA-Seq data for 1 macrophage sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000942 | DNase-Hypersensitivity data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_dnaseseq_analysis_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000931 | DNase-Hypersensitivity data for 1 macrophage sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_dnaseseq_analysis_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000916 | ChIP-Seq data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 7 run(s), 7 experiment(s), 7 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000929 | ChIP-Seq data for 1 macrophage sample(s). 6 run(s), 6 experiment(s), 6 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000906 | ChIP-Seq data for 1 mature eosinophil sample(s). 7 run(s), 7 experiment(s), 7 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00001000927 | Bisulfite-Seq data for 1 Plasma cell sample(s). 11 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000910 | Bisulfite-Seq data for 1 precursor lymphocyte of B lineage sample(s). 8 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000923 | Bisulfite-Seq data for 1 macrophage sample(s). 14 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000909 | Bisulfite-Seq data for 1 erythroblast sample(s). 14 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000921 | Bisulfite-Seq data for 1 CD8-positive, alpha-beta T cell sample(s). 14 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000917 | Bisulfite-Seq data for 1 hematopoietic multipotent progenitor cell sample(s). 8 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000920 | Bisulfite-Seq data for 1 alternatively activated macrophage sample(s). 10 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000932 | Bisulfite-Seq data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 14 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001000943 | Bisulfite-Seq data for 1 germinal center B cell sample(s). 8 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001000284 | Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing | Illumina Genome Analyzer IIx; | 1 | |
| EGAD00001000290 | Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing | Illumina Genome Analyzer IIx; | 1 | |
| EGAD00001001019 | RNA-seq dataset used for the validation of CDK6 cis-regulatory mutation annotated by OncoCis. NB bam files for manuscript A_Proteomic_Chronology_of_Gene_Expression_through_the_Cell_Cycle_in_Human_Myeloid_Leukemia_Cells are now available at the following link:http://www.ebi.ac.uk/ena/data/view/ERP008483 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00010000666 | Purified plasma cells from tonsil of Healthy donor | unknown | 1 | |
| EGAD00001001195 | ChIP-Seq data for 1 effector memory CD8-positive, alpha-beta T cell, terminally differentiated sample(s). 4 run(s), 4 experiment(s), 4 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001144 | ChIP-Seq data for 1 central memory CD4-positive, alpha-beta T cell sample(s). 6 run(s), 6 experiment(s), 6 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001182 | ChIP-Seq data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 7 run(s), 7 experiment(s), 7 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001170 | RNA-Seq data for 1 conventional dendritic cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001142 | RNA-Seq data for 1 endothelial cell of umbilical vein (resting) sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001172 | RNA-Seq data for 1 central memory CD4-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001164 | RNA-Seq data for 1 class switched memory B cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001174 | RNA-Seq data for 1 regulatory T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001175 | RNA-Seq data for 1 central memory CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001163 | RNA-Seq data for 1 effector memory CD4-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001178 | RNA-Seq data for 1 Leukemia sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001166 | RNA-Seq data for 1 endothelial cell of umbilical vein (proliferating) sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001153 | RNA-Seq data for 1 effector memory CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001171 | RNA-Seq data for 1 memory B cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001190 | DNase-Hypersensitivity data for 1 Acute myeloid leukemia sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_dnaseseq_analysis_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001161 | DNase-Hypersensitivity data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_dnaseseq_analysis_20140811 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001160 | Bisulfite-Seq data for 1 plasma cell sample(s). 11 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001001203 | Bisulfite-Seq data for 1 germinal center B cell sample(s). 8 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001001151 | Bisulfite-Seq data for 1 endothelial cell of umbilical vein (proliferating) sample(s). 21 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001134 | Bisulfite-Seq data for 1 precursor lymphocyte of B lineage sample(s). 8 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001001131 | Bisulfite-Seq data for 1 memory B cell sample(s). 20 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001176 | Bisulfite-Seq data for 1 class switched memory B cell sample(s). 20 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001162 | Bisulfite-Seq data for 1 Acute myeloid leukemia sample(s). 18 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001141 | Bisulfite-Seq data for 1 hematopoietic multipotent progenitor cell sample(s). 8 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam,readme_file |
| EGAD00001001150 | Bisulfite-Seq data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 14 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001200 | Bisulfite-Seq data for 1 effector memory CD8-positive, alpha-beta T cell sample(s). 11 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001284 | McGill EMC Release 4 in tissue "Brodmann (1909) area 11" | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001001300 | McGill EMC Release 4 for assay "ATAC-seq": Sequencing of transposase-accessible chromatin as described by Buenrostro et al. (Nature Methods 10, 1213?1218 (2013) doi:10.1038/nmeth.2688) | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001001286 | McGill EMC Release 4 in tissue "Brodmann (1909) area 8;Brodmann (1909) area 9" | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00010000730 | WTCCC2 Psychosis Endophenotype samples from UK, Germany, Holland, Spain and Australia using the Affymetrix 6.0 array | 1 | ||
| EGAD00001002767 | A KNIH008 miRNA-seq single end data for adipocytes | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00010000722 | Pilot experiment on functional genomics in osteoarthritis (coreex) | 1 | ||
| EGAD00001001390 | Human monocytes from a healthy male blood donor were obtained after written informed consent and anonymised. Library preparation was performed essentially as described in the “Wholeâ€genome Bisulfite Sequencing for Methylation Analysis (WGBS)†protocol as released by Illumina. The library was sequenced on an Illumina HiSeq2500 using 101 bp paired-end sequencing. Read mapping was done with BWA. | 1 | bam,readme_file | |
| EGAD00001002768 | A KNIH009 miRNA-seq single end data for preadipocytes | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00010000791 | Illumina HumanOmni2.5-8 BeadChip | 1 | ||
| EGAD00010000748 | Genotyping using Illumina Human OmniExpress12v1.0 | 1 | ||
| EGAD00001001554 | ChIP-Seq data for 1 adult endothelial progenitor cell sample(s). 8 run(s), 7 experiment(s), 7 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001503 | ChIP-Seq data for 1 CD3-positive, CD4-positive, CD8-positive, double positive thymocyte sample(s). 3 run(s), 3 experiment(s), 3 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001577 | ChIP-Seq data for 1 effector memory CD8-positive, alpha-beta T cell, terminally differentiated sample(s). 4 run(s), 4 experiment(s), 4 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001528 | ChIP-Seq data for 1 Leukemia sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001584 | ChIP-Seq data for 1 CD4-positive, alpha-beta thymocyte sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001568 | ChIP-Seq data for 1 CD8-positive, alpha-beta thymocyte sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001557 | ChIP-Seq data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 7 run(s), 6 experiment(s), 6 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001569 | ChIP-Seq data for 1 Acute lymphocytic leukemia - CTR sample(s). 7 run(s), 7 experiment(s), 7 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001478 | RNA-Seq data for 1 CD8-positive, alpha-beta thymocyte sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001489 | RNA-Seq data for 1 CD4-positive, alpha-beta thymocyte sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001547 | RNA-Seq data for 1 central memory CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001570 | ChIP-Seq data for 1 CD3-negative, CD4-positive, CD8-positive, double positive thymocyte sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001525 | RNA-Seq data for 1 mature eosinophil sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001551 | RNA-Seq data for 1 Leukemia sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001540 | RNA-Seq data for 1 conventional dendritic cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001499 | ChIP-Seq data for 1 central memory CD4-positive, alpha-beta T cell sample(s). 9 run(s), 7 experiment(s), 7 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001526 | RNA-Seq data for 1 effector memory CD4-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001578 | ChIP-Seq data for 1 mesenchymal stem cell of the bone marrow sample(s). 9 run(s), 7 experiment(s), 7 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001593 | RNA-Seq data for 1 CD3-positive, CD4-positive, CD8-positive, double positive thymocyte sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001545 | DNase-Hypersensitivity data for 1 alternatively activated macrophage sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_dnaseseq_analysis_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001512 | RNA-Seq data for 1 effector memory CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001549 | DNase-Hypersensitivity data for 1 Acute Myeloid Leukemia sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_dnaseseq_analysis_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001469 | RNA-Seq data for 1 T-cell acute leukemia sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001524 | DNase-Hypersensitivity data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_dnaseseq_analysis_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001475 | DNase-Hypersensitivity data for 1 CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_dnaseseq_analysis_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001531 | RNA-Seq data for 1 class switched memory B cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001536 | ChIP-Seq data for 1 Acute Myeloid Leukemia - MC2884 sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001543 | RNA-Seq data for 1 central memory CD4-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001483 | RNA-Seq data for 1 CD3-negative, CD4-positive, CD8-positive, double positive thymocyte sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001542 | RNA-Seq data for 1 memory B cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001546 | RNA-Seq data for 1 regulatory T cell sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 1 | fastq,bam |
| EGAD00001001583 | Bisulfite-Seq data for 1 effector memory CD8-positive, alpha-beta T cell sample(s). 11 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001565 | Bisulfite-Seq data for 1 monocytes - T=0days sample(s). 15 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001494 | Bisulfite-Seq data for 1 memory B cells sample(s). 1 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001507 | Bisulfite-Seq data for 1 mature eosinophil sample(s). 15 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001479 | Bisulfite-Seq data for 1 memory B cell sample(s). 20 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001530 | Bisulfite-Seq data for 1 Acute Myeloid Leukemia - CTR sample(s). 18 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001509 | Bisulfite-Seq data for 1 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 14 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001587 | Bisulfite-Seq data for 1 germinal center B cell sample(s). 6 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001553 | Bisulfite-Seq data for 1 central memory CD8-positive, alpha-beta T cell sample(s). 13 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001556 | Bisulfite-Seq data for 1 naive B cell sample(s). 5 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001567 | Bisulfite-Seq data for 1 effector memory CD4-positive, alpha-beta T cell sample(s). 15 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001493 | Bisulfite-Seq data for 1 hematopoietic multipotent progenitor cell sample(s). 5 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001541 | Bisulfite-Seq data for 1 effector memory CD8-positive, alpha-beta T cell, terminally differentiated sample(s). 15 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001564 | Bisulfite-Seq data for 1 regulatory T cell sample(s). 15 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001529 | Bisulfite-Seq data for 1 precursor B cell sample(s). 6 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001563 | Bisulfite-Seq data for 1 central memory CD4-positive, alpha-beta T cell sample(s). 15 run(s), 1 experiment(s), 1 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 1 | bam |
| EGAD00001001456 | 1000Genomes imputed data set of 581 cases and 417 controls for male-pattern baldness | 1 | vcf | |
| EGAD00001001602 | Illumina HiSeq 2000; | 1 | fastq | |
| EGAD00001001454 | Previously we performed deep WGS on 6 parents and 13 children from 3 large families from the Scottish Family Health Study to identify de novo mutations. This prelim is cover the additional sequencing of one grandchild from one of these three families. The inclusion of a third generation individual will provide additional experimental validation for the de novo mutations found in the initial trio. As in the previous study, the DNA will be WGS to a depth of approximately 25X to achieve this purpose. These data can only be used for the investigation of the genetic causes of the reported clinical phenotypes in these patients | Illumina HiSeq 2000; | 1 | bam |
| EGAD00010000827 | Illumina Infinium 450K array data | 1 | ||
| EGAD00001001275 | Illumina HiSeq 2000; | 1 | fastq | |
| EGAD00010000815 | ATL tumor samples using Affymetrix 250K SNP array | 1 | ||
| EGAD00010000813 | ATL tumor samples using Illumina 450K Methylation array | 1 | ||
| EGAD00010000811 | ATL tumor samples using Illumina 610K SNP array | 1 | ||
| EGAD00001002755 | A KNIH007 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for adipocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001001663 | Low coverage (4x-8x) Illumina HiSeq curated sequence data from 3 African populations from the AGV project; 100 Baganda from Uganda (4x), 100 Zulu from South Africa (4x), and 120 Gumuz, Wolayta, Oromo, Somali and Amhara from Ethiopia (8x). Pre-processed, jointly called and filtered with GATK, refined with Beagle3, phased with SHAPEIT2. | 1 | vcf | |
| EGAD00001001782 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB8_F | 1 | other | |
| EGAD00001001785 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW12_F | 1 | other | |
| EGAD00001001738 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB38_M | 1 | other | |
| EGAD00001002173 | A KNIH007 mRNA-seq paired end data for adipocytes | Illumina HiSeq 2000;, Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001002161 | Transcriptome from EGAS00001001845 | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001001847 | 4C-seq data was generated for regions of interest to confirm enhancer-gene promoter interactions | Illumina HiSeq 2000; | 1 | fastq |
| EGAD00010000668 | Purified plasma cells from bone marrow of Monoclonal gammopathy of unknown significance patient | unknown | 1 | |
| EGAD00001001917 | PacBio data for mesothelioma cell line NCI-H2595. | PacBio RS II; | 1 | fastq |
| EGAD00001001791 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW15_F | 1 | other | |
| EGAD00001001801 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW22_M | 1 | other | |
| EGAD00001001706 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB22_C | 1 | other | |
| EGAD00001001795 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW18_M | 1 | other | |
| EGAD00001001748 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB43_C | 1 | other | |
| EGAD00001001779 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB62_F | 1 | other | |
| EGAD00001001739 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB40_C | 1 | other | |
| EGAD00001001722 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB28_F | 1 | other | |
| EGAD00001001766 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB55_C | 1 | other | |
| EGAD00001001797 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW20_F | 1 | other | |
| EGAD00001001828 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW47_M | 1 | other | |
| EGAD00001001754 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB4_C | 1 | other | |
| EGAD00001001833 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW4_F | 1 | other | |
| EGAD00001001829 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW49_C | 1 | other | |
| EGAD00001001838 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW51_C | 1 | other | |
| EGAD00001001792 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW15_M | 1 | other | |
| EGAD00001001762 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB51_M | 1 | other | |
| EGAD00001001831 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW49_M | 1 | other | |
| EGAD00001001807 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW27_M | 1 | other | |
| EGAD00001001780 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB62_M | 1 | other | |
| EGAD00001001718 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB27_C | 1 | other | |
| EGAD00001001767 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB55_F | 1 | other | |
| EGAD00001001781 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB8_C | 1 | other | |
| EGAD00001001711 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB23_M | 1 | other | |
| EGAD00001001823 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW46_C | 1 | other | |
| EGAD00001001778 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB62_C | 1 | other | |
| EGAD00001001819 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW38_M | 1 | other | |
| EGAD00001001770 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB57_F | 1 | other | |
| EGAD00001001743 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB41_F | 1 | other | |
| EGAD00001001745 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB42_C | 1 | other | |
| EGAD00001001842 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW52_F | 1 | other | |
| EGAD00001001813 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW2_M | 1 | other | |
| EGAD00001001725 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB30_F | 1 | other | |
| EGAD00001001799 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW22_C | 1 | other | |
| EGAD00001001835 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW50_C | 1 | other | |
| EGAD00001001784 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW12_C | 1 | other | |
| EGAD00001001818 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW38_F | 1 | other | |
| EGAD00001001708 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB22_M | 1 | other | |
| EGAD00001001750 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB43_M | 1 | other | |
| EGAD00001001824 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW46_F | 1 | other | |
| EGAD00001001830 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW49_F | 1 | other | |
| EGAD00001001705 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB21_M | 1 | other | |
| EGAD00001001793 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW18_C | 1 | other | |
| EGAD00001001834 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW4_M | 1 | other | |
| EGAD00001001789 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW14_M | 1 | other | |
| EGAD00001001826 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW47_C | 1 | other | |
| EGAD00001001768 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB55_M | 1 | other | |
| EGAD00001001788 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW14_F | 1 | other | |
| EGAD00001001803 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW24_F | 1 | other | |
| EGAD00001001756 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB4_M | 1 | other | |
| EGAD00001001775 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB60_C | 1 | other | |
| EGAD00001001759 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB50_M | 1 | other | |
| EGAD00001001721 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB28_C | 1 | other | |
| EGAD00001001703 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB21_C | 1 | other | |
| EGAD00001001776 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB60_F | 1 | other | |
| EGAD00001001695 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB10_F | 1 | other | |
| EGAD00001001805 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW27_C | 1 | other | |
| EGAD00001001701 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB1_F | 1 | other | |
| EGAD00001001796 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW20_C | 1 | other | |
| EGAD00001001751 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB44_C | 1 | other | |
| EGAD00001001804 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW24_M | 1 | other | |
| EGAD00001001765 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB52_M | 1 | other | |
| EGAD00001001744 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB41_M | 1 | other | |
| EGAD00001001742 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB41_C | 1 | other | |
| EGAD00001001816 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW32_M | 1 | other | |
| EGAD00001001713 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB24_F | 1 | other | |
| EGAD00001001700 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB1_C | 1 | other | |
| EGAD00001001714 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB24_M | 1 | other | |
| EGAD00001001815 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW32_F | 1 | other | |
| EGAD00001001732 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB33_M | 1 | other | |
| EGAD00001001699 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB15_M | 1 | other | |
| EGAD00001001736 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB38_C | 1 | other | |
| EGAD00001001825 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW46_M | 1 | other | |
| EGAD00001001843 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW52_M | 1 | other | |
| EGAD00001001753 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB44_M | 1 | other | |
| EGAD00001001723 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB28_M | 1 | other | |
| EGAD00001001741 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB40_M | 1 | other | |
| EGAD00001001810 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW29_M | 1 | other | |
| EGAD00001001839 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW51_F | 1 | other | |
| EGAD00001001755 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB4_F | 1 | other | |
| EGAD00001001760 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB51_C | 1 | other | |
| EGAD00001001841 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW52_C | 1 | other | |
| EGAD00001001822 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW3_M | 1 | other | |
| EGAD00001001730 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB33_C | 1 | other | |
| EGAD00001001786 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW12_M | 1 | other | |
| EGAD00001001798 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW20_M | 1 | other | |
| EGAD00001001716 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB25_F | 1 | other | |
| EGAD00001001772 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB58_C | 1 | other | |
| EGAD00001001717 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB25_M | 1 | other | |
| EGAD00001001702 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB1_M | 1 | other | |
| EGAD00001001719 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB27_F | 1 | other | |
| EGAD00001001731 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB33_F | 1 | other | |
| EGAD00001001712 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB24_C | 1 | other | |
| EGAD00001001790 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW15_C | 1 | other | |
| EGAD00001001758 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB50_F | 1 | other | |
| EGAD00001001836 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW50_F | 1 | other | |
| EGAD00001001764 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB52_F | 1 | other | |
| EGAD00001001800 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW22_F | 1 | other | |
| EGAD00001001794 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW18_F | 1 | other | |
| EGAD00001001806 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW27_F | 1 | other | |
| EGAD00001001697 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB15_C | 1 | other | |
| EGAD00001001704 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB21_F | 1 | other | |
| EGAD00001001809 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW29_F | 1 | other | |
| EGAD00001001724 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB30_C | 1 | other | |
| EGAD00001001817 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW38_C | 1 | other | |
| EGAD00001001840 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW51_M | 1 | other | |
| EGAD00001001727 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB31_C | 1 | other | |
| EGAD00001001752 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB44_F | 1 | other | |
| EGAD00001001783 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB8_M | 1 | other | |
| EGAD00001001771 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB57_M | 1 | other | |
| EGAD00001001726 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB30_M | 1 | other | |
| EGAD00001001709 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB23_C | 1 | other | |
| EGAD00001001811 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW2_C | 1 | other | |
| EGAD00001001746 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB42_F | 1 | other | |
| EGAD00001001820 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW3_C | 1 | other | |
| EGAD00001001757 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB50_C | 1 | other | |
| EGAD00001001715 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB25_C | 1 | other | |
| EGAD00001001710 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB23_F | 1 | other | |
| EGAD00001001761 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB51_F | 1 | other | |
| EGAD00001001821 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW3_F | 1 | other | |
| EGAD00001001694 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB10_C | 1 | other | |
| EGAD00001001696 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB10_M | 1 | other | |
| EGAD00001001707 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB22_F | 1 | other | |
| EGAD00001001787 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW14_C | 1 | other | |
| EGAD00001001814 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW32_C | 1 | other | |
| EGAD00001001728 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB31_F | 1 | other | |
| EGAD00001001747 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB42_M | 1 | other | |
| EGAD00001001827 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW47_F | 1 | other | |
| EGAD00001001733 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB35_C | 1 | other | |
| EGAD00001001769 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB57_C | 1 | other | |
| EGAD00001001763 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB52_C | 1 | other | |
| EGAD00001001837 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW50_M | 1 | other | |
| EGAD00001001802 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW24_C | 1 | other | |
| EGAD00001001737 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB38_F | 1 | other | |
| EGAD00001001749 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB43_F | 1 | other | |
| EGAD00001001812 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW2_F | 1 | other | |
| EGAD00001001698 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB15_F | 1 | other | |
| EGAD00001001729 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB31_M | 1 | other | |
| EGAD00001001773 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB58_F | 1 | other | |
| EGAD00001001735 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB35_M | 1 | other | |
| EGAD00001001720 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB27_M | 1 | other | |
| EGAD00001001734 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB35_F | 1 | other | |
| EGAD00001001774 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB58_M | 1 | other | |
| EGAD00001001808 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: MW29_C | 1 | other | |
| EGAD00001001740 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB40_F | 1 | other | |
| EGAD00001001777 | 50 trios were whole genome sequenced with Complete Genomics to a depth of 80x. For each trio the child was affected with severe ID, and the parents were unaffected. All trios were negative for array, targeted gene and whole exome screening. Dataset consists of sample: BvB60_M | 1 | other | |
| EGAD00001001920 | TEST3 dataset containing 1 FASTQ file with mRNA reads. | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001002770 | A KNIH011 miRNA-seq single end data for podocytes | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002086 | Whole-genome sequencing on Illumina HiSeq2000/2500 of Patient-derived xenograft derived from PDO culture derived from colorectal cancer metastasis sample | Illumina HiSeq 2000; | 1 | |
| EGAD00001002255 | Sequencing Data for DEEP Paper: "reChIP-seq reveals widespread bivalency of H3K4me3 and H3K27me3 in CD4+ memory T-Cells" Sample: 51_Hf01_BlCM_Ct (human, female, Blood, CD4+ central memory cell, normal control) Sequencing types are: total RNA, Whole Genome Bisulfite, ChipSeq (H3K27ac, H3K9me3, H3k36me3, H3K4me1, H3k27me3, H3K4me3, Input), reChipSeq (H3K27me3, H3K4me3) | 1 | readme_file,bam | |
| EGAD00001002193 | Single case of T-ALL carrying t(4;6), a novel translocation. | Illumina HiSeq 2000; | 1 | cram |
| EGAD00001002757 | A KNIH009 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for preadipocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002101 | Whole-exome sequencing on Illumina HiSeq2000/2500 of Patient-derived xenograft derived from PDO culture derived from colorectal cancer primary tumor sample | Illumina HiSeq 2000; | 1 | |
| EGAD00010001330 | HipSci - Healthy Normals - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010000912 | SEA 610K | Illumina 610K | 1 | |
| EGAD00001001923 | RNA sequence data for conditionally reprogrammed cells from patient HUB_5 | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001002217 | Merged file of low-coverage WGS from 179 plasma DNA samples from non-cancer controls and cancer patients for assessment of size distribution of plasma nuclear DNA fragments. | Illumina MiSeq; | 1 | bam |
| EGAD00001002177 | A KNIH011 mRNA-seq paired end data for podocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002176 | A KNIH010 mRNA-seq paired end data for podocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002172 | A KNIH006 mRNA-seq paired end data for beta cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002760 | A KNIH001 miRNA-seq single end data for islet cells | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002167 | A KNIH001 mRNA-seq paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002174 | A KNIH008 mRNA-seq paired end data for adipocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002168 | A KNIH002 mRNA-seq paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002175 | A KNIH009 mRNA-seq paired end data for preadipocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002749 | A KNIH001 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002171 | A KNIH005 mRNA-seq paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002750 | A KNIH002 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002169 | A KNIH003 mRNA-seq paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002163 | Transcriptome from EGAS00001001846 | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001002250 | mRNA-Seq, HiSeq 2000 dataset of the Cell-line use case | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002766 | A KNIH007 miRNA-seq single end data for adipocytes | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002754 | A KNIH006 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for beta cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002759 | A KNIH011 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for podocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002756 | A KNIH008 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for adipocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002758 | A KNIH010 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for podocytes | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002764 | A KNIH005 miRNA-seq single end data for islet cells | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002277 | Variation in the Glucose Transporter gene SLC2A2 is associated with glycaemic response to metformin | 1 | phenotype_file | |
| EGAD00010000672 | Purified plasma cells from bone marrow of Multiple myeloma patient | unknown | 1 | |
| EGAD00010000670 | Purified plasma cells from bone marrow of Pooled healthy donors | unknown | 1 | |
| EGAD00001002280 | ChIP-Seq data for 1 Acute Lymphocytic Leukemia - CTR sample(s). 7 run(s), 7 experiment(s), 7 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002342 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MS275 sample(s). 7 run(s), 7 experiment(s), 7 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002420 | ChIP-Seq data for 1 monocyte - T=10day_RANK_M-CSF sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002516 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MC2494 sample(s). 2 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002372 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MC2884 (4h) sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002310 | ChIP-Seq data for 1 conventional dendritic cell sample(s). 4 run(s), 4 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002386 | ChIP-Seq data for 1 CD4-positive, alpha-beta thymocyte sample(s). 3 run(s), 3 experiment(s), 3 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002494 | ChIP-Seq data for 1 CD8-positive, alpha-beta thymocyte sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002510 | ChIP-Seq data for 1 memory B cell sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002357 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MC2884 sample(s). 8 run(s), 8 experiment(s), 8 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002431 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MC3324 sample(s). 2 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002493 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MS-275 (20h) sample(s). 5 run(s), 5 experiment(s), 5 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002344 | ChIP-Seq data for 1 Acute Myeloid Leukemia - MC2884 sample(s). 3 run(s), 3 experiment(s), 3 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002304 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia sample(s). 7 run(s), 7 experiment(s), 7 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002282 | ChIP-Seq data for 1 unswitched memory B cell sample(s). 7 run(s), 7 experiment(s), 7 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002312 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - MC2884 (24h) sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002298 | ChIP-Seq data for 1 Acute Promyelocytic Leukemia - SAHA sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002299 | RNA-Seq data for 1 CD4-positive, alpha-beta thymocyte sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002461 | RNA-Seq data for 1 Acute Promyelocytic Leukemia - MC2884 (24h) sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002365 | RNA-Seq data for 1 blast forming unit erythroid sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002509 | RNA-Seq data for 1 colony forming unit erythroid sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002422 | RNA-Seq data for 1 CD3-negative, CD4-positive, CD8-positive, double positive thymocyte sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002352 | RNA-Seq data for 1 Acute Promyelocytic Leukemia - MC2884 sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002359 | RNA-Seq data for 1 Acute Promyelocytic Leukemia - MC2392 sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002287 | RNA-Seq data for 1 T-cell Acute Lymphocytic Leukemia sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002500 | RNA-Seq data for 1 Acute Promyelocytic Leukemia - MS-275 (20h) sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002351 | RNA-Seq data for 1 regulatory T cell sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002289 | RNA-Seq data for 1 CD8-positive, alpha-beta thymocyte sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002482 | RNA-Seq data for 1 central memory CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002513 | RNA-Seq data for 1 Acute Promyelocytic Leukemia - MC2884 (4h) sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002402 | RNA-Seq data for 1 late basophilic and polychromatophilic erythroblast sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002525 | RNA-Seq data for 1 CD3-positive, CD4-positive, CD8-positive, double positive thymocyte sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002320 | RNA-Seq data for 1 effector memory CD8-positive, alpha-beta T cell, terminally differentiated sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002332 | RNA-Seq data for 1 Acute Lymphocytic Leukemia - CTR sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002414 | RNA-Seq data for 1 unswitched memory B cell sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002347 | RNA-Seq data for 1 memory B cell sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002480 | DNase-Hypersensitivity data for 1 CD4-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_dnaseseq_analysis_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002285 | DNase-Hypersensitivity data for 1 CD8-positive, alpha-beta T cell sample(s). 1 run(s), 1 experiment(s), 1 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_dnaseseq_analysis_20160816 | Illumina HiSeq 2000; | 1 | bam,fastq |
| EGAD00001002502 | Bisulfite-Seq data for 1 monocyte - RPMI_LPS_T=1hr sample(s). 14 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 1 | bam,bcf |
| EGAD00001002394 | Bisulfite-Seq data for 1 monocyte - RPMI_T=4hrs sample(s). 15 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 1 | bam,bcf |
| EGAD00001002302 | Bisulfite-Seq data for 1 monocyte - RPMI_LPS_T=24hrs sample(s). 22 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002440 | Bisulfite-Seq data for 1 thymocyte sample(s). 14 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002371 | Bisulfite-Seq data for 1 monocyte - RPMI_T=6days sample(s). 14 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002472 | Bisulfite-Seq data for 1 Acute Promyelocytic Leukemia - ATRA sample(s). 9 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 1 | bam,bcf |
| EGAD00001002373 | Bisulfite-Seq data for 1 macrophage - T=6days untreated sample(s). 15 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002327 | Bisulfite-Seq data for 1 monocyte - RPMI_BG_T=1hr sample(s). 14 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002410 | Bisulfite-Seq data for 1 macrophage - T=6days B-glucan sample(s). 15 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002441 | Bisulfite-Seq data for 1 monocyte - RPMI_BG_T=24hrs sample(s). 21 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 1 | bam,bcf |
| EGAD00001002301 | Bisulfite-Seq data for 1 monocyte - RPMI_BG_T=4hrs sample(s). 14 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 1 | bam,bcf |
| EGAD00001002330 | Bisulfite-Seq data for 1 precursor B cell sample(s). 6 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002385 | Bisulfite-Seq data for 1 monocyte - RPMI_BG_T=24hrs_RPMI_T=5days sample(s). 18 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002475 | Bisulfite-Seq data for 1 monocyte - Attached_T=1hr sample(s). 23 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 1 | bam,bcf |
| EGAD00001002324 | Bisulfite-Seq data for 1 monocyte - RPMI_LPS_T=24hrs_RPMI_T=5days sample(s). 15 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002291 | Bisulfite-Seq data for 1 precursor lymphocyte of B lineage sample(s). 11 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002405 | Bisulfite-Seq data for 1 monocyte - T=0days sample(s). 15 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002335 | Bisulfite-Seq data for 1 monocyte - RPMI_T=24hrs sample(s). 14 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002432 | Bisulfite-Seq data for 1 monocyte - RPMI_LPS_T=4hrs sample(s). 18 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002447 | Bisulfite-Seq data for 1 monocyte - RPMI_T=1hr sample(s). 15 run(s), 1 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,bcf |
| EGAD00001002270 | We collected fresh tissue from an untreated GBM (SF10282) directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine, resulting in sequencing libraries from 96 individual cells. | Illumina HiSeq 2500; | 1 | fastq |
| EGAD00001002275 | We performed bulk exome-seq on a primary GBM and a blood sample from SF10282 | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002269 | We expressed PDGFRAmut, wild-type PDGFRA and a GFP control from lentivirus, in two primary GBM patient-derived cell lines that we had cultured as monolayers. | Illumina HiSeq 4000; | 1 | fastq |
| EGAD00001002274 | We performed bulk exome-seq on a primary GBM and a blood sample from SF10360 | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002273 | We performed bulk exome-seq on a primary GBM and a blood sample from SF10345 | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002271 | We collected fresh tissue from an untreated GBM (SF10345) directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine, resulting in sequencing libraries from 96 individual cells. | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002272 | We collected fresh tissue from an untreated GBM (SF10360) directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine, resulting in sequencing libraries from 96 individual cells. | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001001949 | HipSci - Monogenic Diabetes - Exome Sequencing - April 2015 | Illumina HiSeq 2000; | 1 | tabix,cram,vcf,bai,bam |
| EGAD00001001953 | HipSci - Monogenic Diabetes - RNA Sequencing - April 2015 | Illumina HiSeq 2000; | 1 | bam,cram,bai |
| EGAD00001002170 | A KNIH004 mRNA-seq paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002761 | A KNIH002 miRNA-seq single end data for islet cells | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002751 | A KNIH003 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002762 | A KNIH003 miRNA-seq single end data for islet cells | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002752 | A KNIH004 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002763 | A KNIH004 miRNA-seq single end data for islet cells | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002753 | A KNIH005 Whole-Genome Bisulfite Sequencing(WGBS) paired end data for islet cells | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002769 | A KNIH010 miRNA-seq single end data for podocytes | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002765 | A KNIH006 miRNA-seq single end data for beta cells | Illumina HiSeq 2500;ILLUMINA | 1 | fastq |
| EGAD00001002899 | ATAC-seq data for 1 sample(s) for monocyte RPMI_T=4hrs from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002909 | ATAC-seq data for 1 sample(s) for monocyte RPMI_BG_T=24hrs from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002921 | ATAC-seq data for 1 sample(s) for monocyte RPMI_T=24hrs from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002911 | ATAC-seq data for 1 sample(s) for germinal center B cell from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002904 | ATAC-seq data for 1 sample(s) for monocyte RPMI_BG_T=24hrs_RPMI_T=5days from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002922 | ATAC-seq data for 1 sample(s) for monocyte RPMI_LPS_T=4hrs from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002906 | ATAC-seq data for 1 sample(s) for monocyte RPMI_BG_T=1hr from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002910 | ATAC-seq data for 1 sample(s) for monocyte RPMI_BG_T=4hrs from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002915 | ATAC-seq data for 1 sample(s) for monocyte RPMI_BG_T=24hrs_RPMI_T=5days_LPS_T=4hrs from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002900 | ATAC-seq data for 1 sample(s) for monocyte RPMI_LPS_T=24hrs from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002919 | ATAC-seq data for 1 sample(s) for monocyte RPMI_T=1hr from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002914 | ATAC-seq data for 1 sample(s) for monocyte RPMI_T=6days from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002913 | ATAC-seq data for 1 sample(s) for monocyte RPMI_LPS_T=1hr from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002969 | Bisulfite-Seq data for 1 sample(s) Acute Lymphocytic Leukemia for precursor B cell from bone marrow, on Genome GRCh38. 3 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | bam |
| EGAD00001002943 | ChIPmentation data for 1 sample(s) for effector memory CD8-positive, alpha-beta T cell, terminally differentiated from venous blood, on Genome GRCh38. 5 run(s), 3 experiment(s), 3 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002932 | ChIPmentation data for 1 sample(s) for germinal center B cell from tonsil, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002948 | ChIP-Seq data for 1 sample(s) for conventional dendritic cell from cord blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002933 | ChIPmentation data for 1 sample(s) for class switched memory B cell from venous blood, on Genome GRCh38. 2 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002951 | ChIP-Seq data for 1 sample(s) for class switched memory B cell from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002926 | ChIPmentation data for 1 sample(s) for effector memory CD4-positive, alpha-beta T cell from venous blood, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002945 | ChIPmentation data for 1 sample(s) for effector memory CD8-positive, alpha-beta T cell from venous blood, on Genome GRCh38. 2 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002950 | ChIP-Seq data for 1 sample(s) for memory B cell from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002927 | ChIPmentation data for 1 sample(s) for central memory CD4-positive, alpha-beta T cell from venous blood, on Genome GRCh38. 5 run(s), 3 experiment(s), 3 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002937 | ChIPmentation data for 1 sample(s) for naive B cell from tonsil, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002934 | ChIPmentation data for 1 sample(s) for cytotoxic CD56-dim natural killer cell from venous blood, on Genome GRCh38. 2 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002930 | ChIPmentation data for 1 sample(s) Acute Lymphocytic Leukemia from bone marrow, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002929 | ChIPmentation data for 1 sample(s) for CD38-negative naive B cell from cord blood, on Genome GRCh38. 5 run(s), 3 experiment(s), 3 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002940 | ChIPmentation data for 1 sample(s) for conventional dendritic cell from cord blood, on Genome GRCh38. 4 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002949 | ChIP-Seq data for 1 sample(s) Acute Lymphocytic Leukemia for precursor B cell from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | bam,fastq |
| EGAD00001002925 | ChIPmentation data for 1 sample(s) for immature conventional dendritic cell GM-CSF_IL4_T=6_days from venous blood, on Genome GRCh38. 2 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002941 | ChIPmentation data for 1 sample(s) for mature conventional dendritic cell GM-CSF_IL4_T=6_days_R848_T=24hrs from venous blood, on Genome GRCh38. 2 run(s), 1 experiment(s), 1 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 1 | bam,fastq |
| EGAD00001002962 | RNA-Seq data for 1 sample(s) Acute Myeloid Leukemia for blast cell from bone marrow, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002961 | RNA-Seq data for 1 sample(s) for monocyte T=10day_S100A9_RANKL_M-CSF from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002959 | RNA-Seq data for 1 sample(s) for monocyte T=1day_M-CSF_S100A9_4hr_RANL from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002960 | RNA-Seq data for 1 sample(s) for monocyte T=6day_S100A9_RANKL_M-CSF from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002967 | RNA-Seq data for 1 sample(s) for monocyte T=6day_RANK_M-CSF from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002965 | RNA-Seq data for 1 sample(s) for monocyte T=2day_S100A9_RANKL_M-CSF from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002957 | RNA-Seq data for 1 sample(s) for monocyte T=2day_RANK_M-CSF from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002964 | RNA-Seq data for 1 sample(s) for monocyte T=1day_4hr_RANK from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002954 | RNA-Seq data for 1 sample(s) Acute Lymphocytic Leukemia from bone marrow, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002966 | RNA-Seq data for 1 sample(s) for monocyte T=10day_RANK_M-CSF from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002955 | RNA-Seq data for 1 sample(s) for monocyte T=0day from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001002958 | RNA-Seq data for 1 sample(s) Acute Myeloid Leukemia from venous blood, on Genome GRCh38. 1 run(s), 1 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 1 | fastq |
| EGAD00001003141 | List of SNPs, and their frequencies, extracted from a low pass whole genome sequencing of 3,514 individuals. | 1 | ||
| EGAD00001003111 | We collected fresh tissue from an untreated GBM directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine after selection of CD11b+ cells using magnetic beads. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003110 | We collected fresh tissue from an untreated GBM directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine after selection of CD11b+ cells using magnetic beads. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003114 | We collected fresh tissue from an untreated GBM (SF10281) directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine, resulting in sequencing libraries from 96 individual cells. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003112 | We collected fresh tissue from an untreated GBM (SF10592) directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine, resulting in sequencing libraries from 96 individual cells. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003107 | We collected fresh tissue from an untreated GBM directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine after selection of CD11b+ cells using magnetic beads. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003108 | We collected fresh tissue from an untreated GBM directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine after selection of CD11b+ cells using magnetic beads. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003109 | We collected fresh tissue from an untreated GBM directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine after selection of CD11b+ cells using magnetic beads. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003113 | We collected fresh tissue from an untreated GBM (SF10679) directly from the operating room and subjected the biopsy to single-cell RNA-seq with the fluidigm C1 machine, resulting in sequencing libraries from 96 individual cells. | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001002075 | RNAseq on Illumina HiSeq2000/2500 of Patient-derived xenograft derived from PDO culture derived from colorectal cancer metastasis sample | Illumina HiSeq 2000; | 1 | |
| EGAD00001002097 | Whole-exome sequencing on Illumina HiSeq2000/2500 of Patient-derived xenograft derived from PDO culture derived from colorectal cancer metastasis sample | Illumina HiSeq 2000; | 1 | |
| EGAD00001002079 | RNAseq on Illumina HiSeq2000/2500 of Patient-derived xenograft derived from PDO culture derived from colorectal cancer primary tumor sample | Illumina HiSeq 2000; | 1 | |
| EGAD00001002090 | Whole-genome sequencing on Illumina HiSeq2000/2500 of Patient-derived xenograft derived from PDO culture derived from colorectal cancer primary tumor sample | Illumina HiSeq 2000; | 1 | |
| EGAD00001002106 | Whole-exome sequencing on AB 5500xl Genetic Analyzer of Patient-derived xenograft derived from colorectal cancer metastasis sample | AB 5500xl Genetic Analyzer; | 1 | |
| EGAD00001003328 | Clinical and genetic information of an individual with RVOT-VT and a KCNK2 (TREK1) gene mutation obtained after whole exome sequencing. | 1 | ||
| EGAD00010001249 | TGCT - GWAS loci Hi-C data | Illumina HiSeq 2000 | 1 | |
| EGAD00001003311 | Dataset contains one sample derived from gDNA of human fibroblasts. Files are in FASTQ format and were generated using the Agilent SureSelect Human All Exon 50Mb Kit and followed by Next Generation Sequencing on a HighSeq2000 instrument (Illumina). | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00001003371 | Whole-genome sequencing on Illumina HiSeq2000/2500 of normal colon control tissue (OT2_cohort) | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00001003365 | RNAseq on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer metastasis sample (OT2_cohort) | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00001003378 | Whole-exome sequencing on Illumina HiSeq2000/2500 of normal colon control tissue (OT2_cohort) | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00001003385 | Whole-exome sequencing on AB 5500xl Genetic Analyzer of Blood EDTA (OT2_cohort) | AB 5500 Genetic Analyzer;ABI_SOLID | 1 | |
| EGAD00001003386 | Whole-exome sequencing on AB 5500xl Genetic Analyzer of colorectal cancer primary tumor sample (OT2_cohort) | AB 5500 Genetic Analyzer;ABI_SOLID | 1 | |
| EGAD00001003373 | Whole-genome sequencing on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer metastasis sample (OT2_cohort) | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00001003368 | RNAseq on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer primary tumor sample (OT2_cohort) | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00001003380 | Whole-exome sequencing on Illumina HiSeq2000/2500 of PDO culture derived from colorectal cancer metastasis sample (OT2_cohort) | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00001003597 | Promoter capture HiC on KMS11 (multiple myeloma) | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00010001340 | HipSci - Bardet-Biedl Syndrome - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001344 | HipSci - Hereditary Cerebellar Ataxias - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001342 | HipSci - Monogenic Diabetes - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00001003483 | A CKD25_C_Podo_mRNA-Seq paired end data for Podocytes(CD90(-) Podocalyxin(+), kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003316 | RNAseq of LC2AD with AD80 or DMSO Plenker et al., Mechanistic insight into RET kinase inhibitors targeting the DFG-out conformation in RET-rearranged cancer | Illumina HiSeq 2000;ILLUMINA | 1 | |
| EGAD00010001234 | CN/LOH-profile of Translocation-negative FL_9 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001238 | CN/LOH-profile of Translocation-negative FL_2 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001237 | CN/LOH-profile of Translocation-negative FL_10 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001233 | CN/LOH-profile of Translocation-negative FL_5 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001240 | CN/LOH-profile of Translocation-negative FL_1 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001236 | CN/LOH-profile of Translocation-negative FL_4 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001241 | CN/LOH-profile of Translocation-negative FL_7 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001232 | CN/LOH-profile of Translocation-negative FL_8 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001239 | CN/LOH-profile of Translocation-negative FL_6 | Affymetrix SNP 6.0 | 1 | |
| EGAD00010001235 | CN/LOH-profile of Translocation-negative FL_11 | Affymetrix SNP 6.0 | 1 | |
| EGAD00001003487 | A OB57_D_PreA_mRNA-Seq paired end data for Preadipocyte(fat) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003482 | A CKD24_C_Podo_mRNA-Seq paired end data for Podocytes(CD90(-) Podocalyxin(+), kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003488 | A IPS01_N_Fibroblast_mRNA-Seq paired end data for iPSC(Oct4) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003478 | A IPS06_X_ENeuron_WGBS paired end data for Early neuron cells(Tuj1) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003501 | A IPS01_N_Fibroblast_smRNA-Seq single end data for iPSC(Oct4) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003491 | A IPS04_X_Fibroblast_mRNA-Seq paired end data for iPSC(Oct4) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003497 | A CKD23_C_Mesan_smRNA-Seq single end data for Mesangial cells(kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003481 | A CKD23_C_Mesan_mRNA-Seq paired end data for Mesangial cells(kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003480 | A OB57_D_PreA_WGBS paired end data for Preadipocyte(fat) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003472 | A DB31_N_Alpha_WGBS paired end data for alpha cells(PSA-NCAM(-), pancreas) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003495 | A OB56_N_PreA_smRNA-Seq single end data for Preadipocytes(fat) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003471 | A CKD27_C_Mesan_WGBS paired end data for Mesangial cells(kidney) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003494 | A DB31_N_Alpha_smRNA-Seq single end data for alpha cells(PSA-NCAM(-), pancreas) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003477 | A IPS05_X_NPC_WGBS paired end data for Neural progenitor cells(Nestin) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003496 | A OB57_D_PreA_smRNA-Seq single end data for Preadipocyte(fat) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003485 | A DB31_N_Alpha_mRNA-Seq paired end data for alpha cells(PSA-NCAM(-), pancreas) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003475 | A IPS03_N_ENeuron_WGBS paired end data for Early neuron cells(Tuj1) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003484 | A CKD27_C_Mesan_mRNA-Seq paired end data for Mesangial cells(kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003504 | A IPS04_X_Fibroblast_smRNA-Seq single end data for iPSC(Oct4) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003479 | A OB56_N_PreA_WGBS paired end data for Preadipocytes(fat) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003489 | A IPS02_N_NPC_mRNA-Seq paired end data for Neural progenitor cells(Nestin) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003474 | A IPS02_N_NPC_WGBS paired end data for Neural progenitor cells(Nestin) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003490 | A IPS03_N_ENeuron_mRNA-Seq paired end data for Early neuron cells(Tuj1) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003506 | A IPS06_X_ENeuron_smRNA-Seq single end data for Early neuron cells(Tuj1) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003499 | A CKD25_C_Podo_smRNA-Seq single end data for Podocytes(CD90(-) Podocalyxin(+), kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003476 | A IPS04_X_Fibroblast_WGBS paired end data for iPSC(Oct4) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003492 | A IPS05_X_NPC_mRNA-Seq paired end data for Neural progenitor cells(Nestin) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003469 | A CKD24_C_Podo_WGBS paired end data for Podocytes(CD90(-) Podocalyxin(+), kidney) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003486 | A OB56_N_PreA_mRNA-Seq paired end data for Preadipocytes(fat) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003493 | A IPS06_X_ENeuron_mRNA-Seq paired end data for Early neuron cells(Tuj1) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003502 | A IPS02_N_NPC_smRNA-Seq single end data for Neural progenitor cells(Nestin) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003473 | A IPS01_N_Fibroblast_WGBS paired end data for iPSC(Oct4) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003468 | A CKD23_C_Mesan_WGBS paired end data for Mesangial cells(kidney) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003470 | A CKD25_C_Podo_WGBS paired end data for Podocytes(CD90(-) Podocalyxin(+), kidney) | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003500 | A CKD27_C_Mesan_smRNA-Seq single end data for Mesangial cells(kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003505 | A IPS05_X_NPC_smRNA-Seq single end data for Neural progenitor cells(Nestin) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003498 | A CKD24_C_Podo_smRNA-Seq single end data for Podocytes(CD90(-) Podocalyxin(+), kidney) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00010001334 | HipSci - Monogenic Diabetes - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00001003440 | One file of patient 16 with WGS done on Illumina HiSeq X-Ten. For research purpose and authorised user only. | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00010001346 | HipSci - Hereditary Spastic Paraplegia - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001348 | HipSci - Kabuki Syndrome - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001350 | HipSci - Usher Syndrome - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001352 | HipSci - Alport Syndrome - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001354 | HipSci - Congenital Hyperinsulinia - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001360 | HipSci - Bleeding and Platelet Disorders - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001362 | HipSci - Macular Dystrophy - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001364 | HipSci - Retinitis Pigmentosa - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001366 | HipSci - Battens Disease - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001368 | HipSci - Hereditary Cerebellar Ataxias - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001370 | HipSci - Hereditary Spastic Paraplegia - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001372 | HipSci - Kabuki Syndrome - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001376 | HipSci - Alport Syndrome - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001378 | HipSci - Congenital Hyperinsulinia - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001380 | HipSci - Hypertrophic Cardiomyopathy - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001382 | HipSci - Primary Immune Deficiency - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001384 | HipSci - Bleeding and Platelet Disorders - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001386 | HipSci - Macular Dystrophy - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001388 | HipSci - Retinitis Pigmentosa - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001390 | HipSci - Battens Disease - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00010001356 | HipSci - Hypertrophic Cardiomyopathy - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001358 | HipSci - Primary Immune Deficiency - Genotyping Array - July 2017 | Illumina | 1 | |
| EGAD00010001374 | HipSci - Usher Syndrome - Expression Array - July 2017 | Illumina | 1 | |
| EGAD00001003503 | A IPS03_N_ENeuron_smRNA-Seq single end data for Early neuron cells(Tuj1) | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003690 | Transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 1 | ||
| EGAD00001003778 | Illumina HiSeq 2000;ILLUMINA | 1 | ||
| EGAD00001003841 | One sample of human genomic DNA. DNA extracted from whole blood. Reads obtained using an exome enrichment kit (Truseq, Illumina) and sequencing of 100bp paired-end reads on a HiSeq 2500 sequencing system (Illumina). | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003870 | A ADMSC04_smRNA-Seq single end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003861 | A SMC04_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003854 | A ADMSC01_ChIP-Seq(H3K27me3) paired end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003856 | A ADMSC03_ChIP-Seq(H3K27me3) paired end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003873 | A SMC05_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003880 | A ADMSC03_WGBS paired end data for adipose-derived mesenchymal stem cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003869 | A ADMSC03_smRNA-Seq single end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003863 | A SMC06_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003874 | A SMC06_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003881 | A ADMSC04_WGBS paired end data for adipose-derived mesenchymal stem cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003876 | A SMC08_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003858 | A SMC01_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003850 | A SMC06_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003847 | A SMC03_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003853 | A SMC09_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003852 | A SMC08_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003848 | A SMC04_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003875 | A SMC07_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003859 | A SMC02_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003851 | A SMC07_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003879 | A ADMSC02_WGBS paired end data for adipose-derived mesenchymal stem cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003868 | A ADMSC02_smRNA-Seq single end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003871 | A SMC01_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003867 | A ADMSC01_smRNA-Seq single end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003860 | A SMC03_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003878 | A ADMSC01_WGBS paired end data for adipose-derived mesenchymal stem cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003865 | A SMC08_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003845 | A SMC01_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003857 | A ADMSC04_ChIP-Seq(H3K27me3) paired end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003846 | A SMC02_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003862 | A SMC05_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003849 | A SMC05_ChIP-Seq(H3K27me3) paired end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003866 | A SMC09_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003877 | A SMC09_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003864 | A SMC07_smRNA-Seq single end data for skletal muscle cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003855 | A ADMSC02_ChIP-Seq(H3K27me3) paired end data for adipose-derived mesenchymal stem cells | Illumina HiSeq 2500;ILLUMINA | 1 | |
| EGAD00001003872 | A SMC02_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003888 | A SMC03_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00001003889 | A SMC04_WGBS paired end data for skletal muscle cells | HiSeq X Ten;ILLUMINA | 1 | |
| EGAD00010001474 | UK BioBank Imputed Dataset | 1 | ||
| EGAD00001004081 | Smart-seq2 protocol was used to perform single cell RNA-sequencing on 465 immune cells. The immune cells analysed include 215 HLA-DQ2: gluten-(DQ2.5-glia-α1, -α2, -ω1, and -ω2) tetramer-sorted T cells, 247 transglutaminase 2 (TG2)-positive plasma cells from intestinal biopsy or peripheral blood from celiac disease patients, and 3 unassigned cells in 3 batches. | Illumina HiSeq 4000;ILLUMINA | 1 | |
| EGAD00001004131 | Pheno-seq is a new approach that integrates high-throughput imaging and transcriptomic profiling of clonal spheroids/organoids to dissect functional tumor cell heterogeneity in 3D cell culture systems. The method is based on the iCELL8 technology (TakaraBio) that uses barcoded nanowells and a micro-solenoid valve dispenser. The CRC_spheroid dataset contains demultiplexed RNA-sequencing profiles (FASTQ file format, NextSeq 500) of 95 clonal tumor spheroids derived from a patient with colorectal cancer. | NextSeq 500;ILLUMINA | 1 | |
| EGAD00001000396 | We performed serial plasma-Seq analyses on a male who progressed from castration-sensitive to castration-resistant prostate cancer within 10 months following treatment with androgen-deprivation therapy. | Illumina MiSeq; | 2 | fastq |
| EGAD00010000130 | Cerebellar ataxia, mental retardation, and disequilibrium syndrome (CAMRQ) samples | Illumina 300 Duo V2 - Bead Studio, Illumina | 2 | |
| EGAD00000000055 | COLO-829 is a publicly available immortal cancer cell line and COLO-829BL is a lymphoblastoid cell line derived from the same patient | Illumina Genome Analyzer II | 2 | |
| EGAD00001000149 | A Comprehensive Catalogue of Somatic Mutations from a Human Cancer Genome | Illumina HiSeq 2000 | 2 | srf |
| EGAD00001000224 | Enrichment of CRC | 454 GS FLX Titanium; | 2 | bam |
| EGAD00010000379 | DNA methylation analysis of 2 peripheral blood samples | HumanMethylation450k Bead Chip - Genome Studio | 2 | |
| EGAD00001000359 | In this study we will sequence the transcriptome of Verified Cancer Cell lines. This will be married up to whole exome and whole genome sequencing data to establish a full catalog of the variations and mutations found. | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001000048 | monozygotic twin discordant for schizophrenia | CompleteGenomics build 1.4.2.8 - CG Build 1.4.2.8 | 2 | CompleteGenomics_native |
| EGAD00010000220 | Ovarian & matched normal (Genotypes) | Complete Genomics - CG Build 1.4.2.8 | 2 | |
| EGAD00001000607 | PCR products were obtained from each target loci using genomic DNA from human iPS cells. Subsequently, PCR products are pooled and subjected to Illumina library preparation. The library will be sequenced either by HiSeq or MiSeq. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/ | Illumina MiSeq; | 2 | bam |
| EGAD00001000634 | The ETV6-RUNX1 fusion gene, found in 25% of childhood acute lymphoblastic leukemia (ALL), is acquired in utero but requires additional somatic mutations for overt leukemia. We used exome and low-coverage whole-genome sequencing to characterize the critical secondary events associated with leukemic transformation. RAG-mediated deletions emerge as the dominant mutational process, accounting for at least 43% of genomic rearrangements and characterized by the presence of recombination signal sequence motifs near the breakpoints; incorporation of non-templated sequence at the junction and a ten-fold enrichment at promoters and enhancers of genes actively transcribed in early B-lineage development. Single-cell tracking shows that this mechanism is not restricted to one founder cell but is rather active throughout leukemic evolution. Integration of point mutation and rearrangement data identifies recurrent inactivation of ATF7IP and MGA as two new tumor suppressor genes.Thus, a remarkably parsimonious mutational process transforms ETV6-RUNX1 lymphoblasts, striking promoters and enhancers of the genes that normally control B-cell differentiation. | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001287 | McGill EMC Release 4 in tissue "kidney" | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001000642 | Illumina HiScanSQ; | 2 | bam | |
| EGAD00001000643 | Illumina HiScanSQ; | 2 | bam | |
| EGAD00001001326 | Whole genome sequencing of single adult t-cell leukemia/lymphoma case | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001260 | Illumina HiSeq 2000; | 2 | fastq | |
| EGAD00001000693 | The genetic consequences of cellular transformation by Epstein-Barr-Virus were assessed by comparing whole genome sequences of the original genome (before transformation) and the genome after transformation. | 2 | bam,vcf | |
| EGAD00001000625 | The main objective of this benchmark is the comparison of the full sequencing pipeline of different ICGC partners, including procedures, methods and performance of library preparation and whole-genome deep-sequencing. A secondary objective will be a follow-up comparison of data analysis pipelines for identification of germline and somatic variants subsequent to the results of the ICGC Somatic Variant Calling Pipeline Benchmark. | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001000757 | UK10K_RARE_SIR UK10K_EXOME_EXTRAS | Illumina HiSeq 2000; | 2 | tabix,vcf |
| EGAD00001000779 | AB SOLiD 4 System; | 2 | bam | |
| EGAD00001000847 | Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by exocrine pancreatic insufficiency, bone marrow dysfunction, leukemia predisposition, and skeletal abnormalities. We aim to characterise the structural effects of SDS in patients with this disorder by exome sequencing. | Illumina HiSeq 2000; | 2 | cram |
| EGAD00001000805 | UK10K_RARE_THYWG REL-2013-03-06 | Illumina HiSeq 2000; | 2 | tabix,vcf |
| EGAD00001000803 | UK10K_RARE_FINDWG REL-2013-03-06 | Illumina HiSeq 2000; | 2 | tabix,vcf |
| EGAD00001000802 | UK10K_RARE_CILWG REL-2013-03-06 | Illumina HiSeq 2000; | 2 | tabix,vcf |
| EGAD00001000926 | DNase-Hypersensitivity data for 2 inflammatory macrophage sample(s). 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_dnaseseq_analysis_20140811 | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001000924 | ChIP-Seq data for 2 erythroblast sample(s). 14 run(s), 14 experiment(s), 14 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001000936 | ChIP-Seq data for 2 CD8-positive, alpha-beta T cell sample(s). 13 run(s), 13 experiment(s), 13 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001000934 | Bisulfite-Seq data for 2 Multiple myeloma sample(s). 16 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 2 | bam,readme_file |
| EGAD00001001242 | Pilot study to set up sequencing protocols for targeted pulldown methylation profiling | Illumina MiSeq; | 2 | cram |
| EGAD00001001259 | Illumina HiSeq 2000; | 2 | fastq | |
| EGAD00001001261 | Bisulfite-Seq of CD14-positive, CD16-negative classical monocyte samples for methylome saturation and COMET analysis | Illumina HiSeq 2000; | 2 | bam,readme_file |
| EGAD00001001123 | Deep sequencing of two skin biopsies to study the landscape of somatic mutations in human adult tissues. | Illumina HiSeq 2000; | 2 | cram |
| EGAD00001000997 | Whole-exome sequencing of a chronic lymphocytic leukemia (CLL) developed during vemurafenib treatment of a patient with malignant melanoma. Peripheral blood mononuclear cells were separated by Ficoll gradient centrifugation. DNA was extracted from highly purified (>97%) CD19+CD5+ cells obtained from the patient while being under BRAF inhibition versus CD14+ germline control cells (>90% purity). No alterations that could be linked to aberrant RAS activity or paradoxical RAF/MEK/ERK signaling could be identified in the CLL, which shows characteristic copy number alterations. | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001001001 | 2 | bam | ||
| EGAD00001001033 | Whole exome sequencing (WES) was performed on genomic DNA derived from two patients with Sotos Syndrome Features. Sequencing (100 base pair paired-end) was performed on an Illumina Hiseq 2000 sequencer after enrichment of 62Mb of exonic and adjacent intronic sequences with TruSeq Exome Enrichment Kit (Illumina, San Diego, CA, USA). | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001001044 | Ion Torrent PGM; | 2 | bam | |
| EGAD00001001063 | Chondromxoid fibroma is a benign tumour of bone with unknown underlying pathogenesis. To determine pathognomic genomic event in chondromyxoid fibroma whole genome sequencing will be undertaken to reconstruct rearrangements and find underlying mutations. | Illumina HiSeq 2000; | 2 | bam,cram |
| EGAD00001001859 | Raw fastq files for sequence data generated at 5 sequencing centers from a Medulloblastoma sample and matching blood normal control. | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001001858 | Raw fastq files from WGS sequencing of CLL and matching blood normal for the ICGC Techval Benchmark1 study. Sequence data was provided to multiple centers for independent analysis and comparison. | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001001083 | Illumina HiSeq 2000; | 2 | fastq | |
| EGAD00001001127 | ChIP-Seq data for 2 effector memory CD8-positive, alpha-beta T cell sample(s). 10 run(s), 10 experiment(s), 10 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001183 | ChIP-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 10 run(s), 10 experiment(s), 10 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001197 | ChIP-Seq data for 2 monocyte sample(s). 7 run(s), 7 experiment(s), 7 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000;, NextSeq 500; | 2 | fastq,bam |
| EGAD00001001194 | ChIP-Seq data for 2 erythroblast sample(s). 14 run(s), 14 experiment(s), 14 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam,readme_file |
| EGAD00001001168 | ChIP-Seq data for 2 mature eosinophil sample(s). 12 run(s), 12 experiment(s), 12 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001136 | ChIP-Seq data for 2 endothelial cell of umbilical vein (proliferating) sample(s). 13 run(s), 13 experiment(s), 13 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001145 | RNA-Seq data for 2 CD38-negative naive B cell sample(s). 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001137 | RNA-Seq data for 2 CD8-positive, alpha-beta T cell sample(s). 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 2 | fastq,readme_file,bam |
| EGAD00001001193 | DNase-Hypersensitivity data for 2 inflammatory macrophage sample(s). 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_dnaseseq_analysis_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam,readme_file |
| EGAD00001001180 | Bisulfite-Seq data for 2 central memory CD8-positive, alpha-beta T cell sample(s). 27 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001133 | Bisulfite-Seq data for 2 erythroblast sample(s). 35 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 2 | bam,readme_file |
| EGAD00001001135 | Bisulfite-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001152 | Bisulfite-Seq data for 2 Multiple myeloma sample(s). 16 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 2 | bam,readme_file |
| EGAD00001001185 | DNase-Hypersensitivity data for 2 monocyte sample(s). 4 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT release January 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_dnaseseq_analysis_20140811 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001302 | Illumina HiSeq 2500; | 2 | bam | |
| EGAD00001001351 | Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001353 | Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001384 | Mutations that activate the RAF-MEK-ERK signaling pathway, in particular BRAFV600E, occur in many cancers, and mutant BRAF-selective inhibitors have clinical activity in these diseases. Activating BRAF alleles are usually considered to be mutually exclusive with mutant RAS, whereas inactivating mutations in the D594F595G596 motif of the BRAF activation segment can coexist with oncogenic RAS and cooperate via paradoxical MEK/ERK activation. We determined the functional consequences of a largely uncharacterized BRAF mutation, F595L, which was detected along with an HRASQ61R allele by clinical exome sequencing in a patient with histiocytic sarcoma and also occurs in epithelial cancers, melanoma, and neuroblastoma, and investigated its interaction with mutant RAS. We demonstrate that, unlike previously described DFG motif mutants, BRAFF595L is a gain-of-function variant with intermediate activity towards MEK that does not act paradoxically, but nevertheless cooperates with mutant RAS to promote oncogenic signaling. Of immediate clinical relevance, BRAFF595L shows divergent responses to different mutant BRAF-selective inhibitors, whereas signaling driven by BRAFF595L with and without mutant RAS is efficiently blocked by pan-RAF and MEK inhibitors. Mutation data from primary patient samples and cell lines show that BRAFF595L, as well as other BRAF mutations with intermediate activity, frequently coincide with mutant RAS in a broad spectrum of cancers. These data define a novel class of activating BRAF mutations that cooperate with oncogenic RAS in a non-paradoxical fashion to achieve an optimal level of MEK-ERK signaling, extend the spectrum of patients with systemic histiocytic disorders and other malignancies who are candidates for therapeutic blockade of the RAF-MEK-ERK pathway, and underscore the value of comprehensive genetic profiling for understanding the signaling requirements of individual cancers. | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001001310 | Genome and transcriptome sequence data from a peritoneal mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001001415 | DATA FILES FOR PCGP Dyer_iPSC WGS | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001429 | Profiling subclonal architecture and phylogeny in tumors by whole-genome sequence data mining and single-cell genome sequencing | HiSeq X Ten; | 2 | cram |
| EGAD00001001539 | ChIP-Seq data for 2 mature eosinophil sample(s). 12 run(s), 12 experiment(s), 12 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001487 | ChIP-Seq data for 2 endothelial cell of umbilical vein (proliferating) sample(s). 12 run(s), 12 experiment(s), 12 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001502 | ChIP-Seq data for 2 germinal center B cell sample(s). 12 run(s), 11 experiment(s), 11 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001559 | ChIP-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 11 run(s), 11 experiment(s), 11 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001470 | ChIP-Seq data for 2 plasma cell sample(s). 13 run(s), 12 experiment(s), 12 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001472 | ChIP-Seq data for 2 effector memory CD8-positive, alpha-beta T cell sample(s). 10 run(s), 10 experiment(s), 10 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001488 | RNA-Seq data for 2 CD8-positive, alpha-beta T cell sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001580 | ChIP-Seq data for 2 monocyte sample(s). 6 run(s), 6 experiment(s), 6 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000;, NextSeq 500; | 2 | fastq,bam |
| EGAD00001001592 | ChIP-Seq data for 2 Multiple myeloma sample(s). 16 run(s), 14 experiment(s), 14 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001496 | RNA-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001574 | ChIP-Seq data for 2 erythroblast sample(s). 12 run(s), 12 experiment(s), 12 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_chipseq_analysis_ebi_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001566 | RNA-Seq data for 2 neutrophilic metamyelocyte sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001535 | RNA-Seq data for 2 endothelial cell of umbilical vein (proliferating) sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001500 | RNA-Seq data for 2 CD38-negative naive B cell sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_rnaseq_analysis_crg_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001473 | Bisulfite-Seq data for 2 cytotoxic CD56-dim natural killer cell sample(s). 24 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000;ILLUMINA | 2 | bam |
| EGAD00001001522 | Bisulfite-Seq data for 2 plasma cell sample(s). 17 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001497 | Bisulfite-Seq data for 2 conventional dendritic cell sample(s). 30 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001486 | Bisulfite-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 2 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001484 | Bisulfite-Seq data for 2 erythroblast sample(s). 35 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001548 | Bisulfite-Seq data for 2 class switched memory B cell sample(s). 21 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001510 | Bisulfite-Seq data for 2 endothelial cell of umbilical vein (proliferating) sample(s). 36 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_bisulphite_analysis_CNAG_20150820 | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001560 | DNase-Hypersensitivity data for 2 monocyte sample(s). 4 run(s), 2 experiment(s), 2 alignment(s) on human genome GRCh38. Part of BLUEPRINT release August 2015. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20150820/homo_sapiens/README_dnaseseq_analysis_20150820 | Illumina HiSeq 2000; | 2 | fastq,bam |
| EGAD00001001616 | 2 | bam | ||
| EGAD00001001600 | PCR and MiSeq validation for early embryonic substitution candidates from 400 Breast cancer patients. This dataset contains all the data available for this study on 2015-09-03. | Illumina MiSeq; | 2 | cram |
| EGAD00001001633 | BAM files for two WES TRAIP patients | Illumina HiSeq 2000; | 2 | bam |
| EGAD00001001686 | In the autozygosity exome sequencing of Born-in-Bradford samples of Pakistani origin there is a mother who is homozygous for an apparent truncating stop codon in PRDM9, the gene responsible for localising recombination during meiosis. We plan to deep sequence mother and child with X10, and physically phase the mother with PacBio sequencing. We will use this data to identify recombination locations, and test whether these are consistent with the known fine scale recombination map. Data Access is controlled by the Wellcome Trust Sanger Institute DAC and the Born In Bradford Executive Group. | Illumina HiSeq 2500; | 2 | cram |
| EGAD00001002159 | Exome Seq for Study EGAS00001001844 | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001002160 | Exome Seq for EGAS00001001845 | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001002162 | Exome Seq from EGAS00001001846 | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001001658 | Genome and transcriptome sequence data from an odontogenic ghost cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001001968 | Genome and transcriptome sequence data from a non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001001969 | Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00010000909 | HipSci - Embryonic Stem Cells - Methylation Array - April 2016 | Illumina | 2 | |
| EGAD00001001656 | Genome and transcriptome sequence data from an atypical chronic lymphocytic leukemia patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001001093 | Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001002216 | RNA-Seq on an Ion Torrent Proton of corresponding tumor material of two metastasized breast cancer patients (Breast7, Breast13). | Ion Torrent Proton; | 2 | |
| EGAD00001001999 | HipSci - Embryonic Stem Cells - Exome Sequencing - April 2016 | Illumina HiSeq 2000; | 2 | cram |
| EGAD00001002000 | HipSci - Embryonic Stem Cells - RNA Sequencing - April 2016 | Illumina HiSeq 2000; | 2 | cram |
| EGAD00010000910 | HipSci - Embryonic Stem Cells - Expression Array - April 2016 | Illumina | 2 | |
| EGAD00010000911 | HipSci - Embryonic Stem Cells - Genotyping Array - April 2016 | Illumina | 2 | |
| EGAD00001002005 | Using whole exome sequencing (WES), we identified homozygosity for a missense variant, VPS11: c.2536T>G (p.C846G), as the genetic cause of a leukoencephalopathy syndrome in two individuals from two unrelated Ashkenazi Jewish (AJ) families. Both patients exhibited highly concordant disease progression characterized by infantile onset leukoencephalopathy with brain white matter abnormalities, severe motor impairment, cortical blindness, intellectual disability, and seizures. | 2 | vcf | |
| EGAD00001002043 | Genome and transcriptome sequence data from a recurrent glioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002037 | Genome and transcriptome sequence data from an adrenal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002034 | Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002023 | Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002020 | Genome and transcriptome sequence data from a metastatic NPC patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002045 | Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002049 | Genome and transcriptome sequence data from an adrenal cortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002019 | Genome and transcriptome sequence data from a patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002182 | The BMP antagonist Grem1 has been shown to be associated with a rare human polyposis syndrome (HMPS). We have shown that there is a 40KB duplication on chrom 15 found in some patients with HMPS. Traditional serrated adenomas (rare sporadic polyps) share some morphological features with HMPS polyps and it has long been hypothesised that they are the sporadic version of HMPS polyps. We have obtained of one of these lesions and in this project we aim to characterise this tumour. | Illumina HiSeq 2000; | 2 | cram |
| EGAD00001002184 | Sequencing of rare human histiocytic tumour | Illumina HiSeq 2000; | 2 | cram |
| EGAD00001002199 | Sequencing of rare human histiocytic tumour | Illumina HiSeq 2000; | 2 | cram |
| EGAD00010000919 | samples using Illumina HUMANOMNI1QUAD | HUMANOMNI1QUAD | 2 | |
| EGAD00001002164 | Exome from EGA00001001848 | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001002243 | RNA-seq data for patient samples | Illumina HiSeq 2500; | 2 | fastq |
| EGAD00001001386 | Whole Genome Sequencing of Huh7 cell lines | Illumina HiSeq 2000; | 2 | fastq |
| EGAD00001002069 | Complete genomics data for VCaP and PC346c. | 2 | other | |
| EGAD00001002252 | This data set contains next generation sequencing (NGS) data of two serial tumor samples (primary and a metastasis) from a patient with colorectal cancer showing an ERBB2 c.2264T>C (p.Leu755Ser). NGS was performed using the Illumina TruSeq Amplicon Cancer Panel (TSACP, Illumina) covering 212 amplicons in 48 cancer associated genes on the Illumina MiSeq sequencing platform. The dataset contains two BAM files. | Illumina MiSeq; | 2 | bam |
| EGAD00001002917 | ATAC-seq data for 2 sample(s) for germinal center B cell from tonsil, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002406 | ChIP-Seq data for 2 Acute Promyelocytic Leukemia - MC2392 sample(s). 14 run(s), 12 experiment(s), 12 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002297 | ChIP-Seq data for 2 monocyte - RPMI_BG_T=1hr sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA, unspecified;ILLUMINA | 2 | bam,fastq |
| EGAD00001002293 | ChIP-Seq data for 2 regulatory T cell sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002453 | ChIP-Seq data for 2 monocyte - RPMI_T=1hr sample(s). 4 run(s), 4 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | unspecified;, Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002477 | ChIP-Seq data for 2 mature eosinophil sample(s). 14 run(s), 14 experiment(s), 14 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002391 | ChIP-Seq data for 2 osteoclast sample(s). 17 run(s), 14 experiment(s), 14 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002491 | ChIP-Seq data for 2 monocyte - T=0days sample(s). 7 run(s), 7 experiment(s), 7 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;, NextSeq 500; | 2 | bam,fastq |
| EGAD00001002399 | ChIP-Seq data for 2 monocyte - RPMI_LPS_T=4hrs sample(s). 5 run(s), 5 experiment(s), 5 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002503 | ChIP-Seq data for 2 effector memory CD8-positive, alpha-beta T cell, terminally differentiated sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002514 | ChIP-Seq data for 2 effector memory CD4-positive, alpha-beta T cell sample(s). 8 run(s), 7 experiment(s), 7 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002381 | ChIP-Seq data for 2 mesenchymal stem cell of the bone marrow sample(s). 16 run(s), 14 experiment(s), 14 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002369 | ChIP-Seq data for 2 CD3-negative, CD4-positive, CD8-positive, double positive thymocyte sample(s). 7 run(s), 5 experiment(s), 5 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002424 | ChIP-Seq data for 2 endothelial cell of umbilical vein (proliferating) sample(s). 14 run(s), 14 experiment(s), 14 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002487 | ChIP-Seq data for 2 adult endothelial progenitor cell sample(s). 16 run(s), 14 experiment(s), 14 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002377 | ChIP-Seq data for 2 erythroblast sample(s). 14 run(s), 14 experiment(s), 14 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002488 | ChIP-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 13 run(s), 13 experiment(s), 13 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002376 | ChIP-Seq data for 2 monocyte - RPMI_LPS_T=1hr sample(s). 8 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA, unspecified;ILLUMINA | 2 | bam,fastq |
| EGAD00001002456 | RNA-Seq data for 2 effector memory CD8-positive, alpha-beta T cell sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002375 | RNA-Seq data for 2 monocyte sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002345 | RNA-Seq data for 2 conventional dendritic cell sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002343 | RNA-Seq data for 2 Acute Myeloid Leukemia - SAHA sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002469 | RNA-Seq data for 2 effector memory CD4-positive, alpha-beta T cell sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002479 | RNA-Seq data for 2 osteoclast sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002326 | RNA-Seq data for 2 mature eosinophil sample(s). 3 run(s), 3 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002473 | RNA-Seq data for 2 mesenchymal stem cell of the bone marrow sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002349 | RNA-Seq data for 2 central memory CD4-positive, alpha-beta T cell sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002341 | RNA-Seq data for 2 endothelial cell of umbilical vein (proliferating) sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002295 | RNA-Seq data for 2 CD8-positive, alpha-beta T cell sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002436 | RNA-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002334 | RNA-Seq data for 2 adult endothelial progenitor cell sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_rnaseq_analysis_crg_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002481 | DNase-Hypersensitivity data for 2 alternatively activated macrophage sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_dnaseseq_analysis_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002499 | DNase-Hypersensitivity data for 2 Acute Lymphocytic Leukemia - CTR sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_dnaseseq_analysis_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002459 | DNase-Hypersensitivity data for 2 Chronic Lymphocytic Leukemia sample(s). 2 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_dnaseseq_analysis_20160816 | Illumina HiSeq 2000; | 2 | bam,fastq |
| EGAD00001002437 | Bisulfite-Seq data for 2 conventional dendritic cell sample(s). 30 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002364 | Bisulfite-Seq data for 2 central memory CD4-positive, alpha-beta T cell sample(s). 41 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002395 | Bisulfite-Seq data for 2 monocyte - None sample(s). 70 run(s), 4 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA, Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002311 | Bisulfite-Seq data for 2 CD34-negative, CD41-positive, CD42-positive megakaryocyte cell sample(s). 29 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA, Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002346 | Bisulfite-Seq data for 2 effector memory CD8-positive, alpha-beta T cell, terminally differentiated sample(s). 34 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002519 | Bisulfite-Seq data for 2 mesenchymal stem cell of the bone marrow sample(s). 39 run(s), 4 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002325 | Bisulfite-Seq data for 2 CD3-positive, CD4-positive, CD8-positive, double positive thymocyte sample(s). 29 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002309 | Bisulfite-Seq data for 2 mature eosinophil sample(s). 23 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002367 | Bisulfite-Seq data for 2 effector memory CD4-positive, alpha-beta T cell sample(s). 34 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA, Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002294 | Bisulfite-Seq data for 2 endothelial cell of umbilical vein (resting) sample(s). 35 run(s), 4 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002423 | Bisulfite-Seq data for 2 erythroblast sample(s). 35 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002451 | Bisulfite-Seq data for 2 endothelial cell of umbilical vein (proliferating) sample(s). 36 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002333 | Bisulfite-Seq data for 2 Acute Myeloid Leukemia - CTR sample(s). 28 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002407 | Bisulfite-Seq data for 2 Acute Promyelocytic Leukemia - CTR sample(s). 27 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002464 | Bisulfite-Seq data for 2 CD3-negative, CD4-positive, CD8-positive, double positive thymocyte sample(s). 29 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002370 | Bisulfite-Seq data for 2 CD8-positive, alpha-beta thymocyte sample(s). 28 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002486 | Bisulfite-Seq data for 2 central memory CD8-positive, alpha-beta T cell sample(s). 36 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002483 | Bisulfite-Seq data for 2 CD4-positive, alpha-beta thymocyte sample(s). 29 run(s), 2 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002492 | Bisulfite-Seq data for 2 regulatory T cell sample(s). 41 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000; | 2 | bcf,bam |
| EGAD00001002434 | Bisulfite-Seq data for 2 hematopoietic multipotent progenitor cell sample(s). 16 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002383 | Bisulfite-Seq data for 2 effector memory CD8-positive, alpha-beta T cell sample(s). 30 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002427 | Bisulfite-Seq data for 2 osteoclast sample(s). 88 run(s), 4 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002404 | Bisulfite-Seq data for 2 adult endothelial progenitor cell sample(s). 38 run(s), 3 experiment(s), 4 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_bisulphite_analysis_CNAG_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bcf,bam |
| EGAD00001002458 | ChIP-Seq data for 2 macrophage - T=6days untreated sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;, NextSeq 500; | 2 | bam,fastq |
| EGAD00001002314 | ChIP-Seq data for 2 macrophage - T=6days B-glucan sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;ILLUMINA, NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002498 | ChIP-Seq data for 2 macrophage - T=6days LPS sample(s). 6 run(s), 6 experiment(s), 6 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_chipseq_analysis_ebi_20160816 | Illumina HiSeq 2000;, NextSeq 500; | 2 | bam,fastq |
| EGAD00001002300 | DNase-Hypersensitivity data for 2 monocyte - T=0days sample(s). 4 run(s), 2 experiment(s), 2 analysis(s) on human genome GRCh38. Part of BLUEPRINT release August 2016. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20160816/homo_sapiens/README_dnaseseq_analysis_20160816 | Illumina HiSeq 2000;ILLUMINA | 2 | bam,fastq |
| EGAD00001002655 | BLUEPRINT ChIP-Seq from two mantle cell lymphoma patients | Illumina HiSeq 2000;ILLUMINA, Illumina HiSeq 2000; | 2 | fastq |
| EGAD00010000936 | Affymetrix Exon Array dataset | Affymetrix GeneChip Human Exon 1.0 ST | 2 | |
| EGAD00010000934 | Agilent miRNA dataset | Agilent SurePrint Human miRNA Microarray | 2 | |
| EGAD00010000939 | Illumina 1M SNP Array dataset | Illumina 1M SNP Array | 2 | |
| EGAD00001002537 | Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002541 | Genome and transcriptome sequence data from a liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002548 | Genome and transcriptome sequence data from a lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002554 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002552 | Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002549 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002545 | Genome and transcriptome sequence data from a duodenal malignancy patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002547 | Exome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002553 | Genome and transcriptome sequence data from an unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002546 | Genome and transcriptome sequence data from a melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002533 | Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002557 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002637 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002580 | Genome and transcriptome sequence data from a right breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002609 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002604 | Genome and transcriptome sequence data from a clear cell carcinoma of ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002568 | Genome and transcriptome sequence data from a metastatic endometrial cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002639 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002628 | Genome and transcriptome sequence data from a squamous cell carcinoma of anus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002579 | Genome and transcriptome sequence data from a carcinoma of left lower outer quadrant patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002636 | Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002622 | Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002559 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002558 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002575 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002648 | Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002611 | Genome and transcriptome sequence data from an adenocarcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002573 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002598 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002621 | Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002647 | Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002638 | Genome and transcriptome sequence data from a metastatic prostate cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002642 | Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002584 | Genome and transcriptome sequence data from a vulvar metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002592 | Genome and transcriptome sequence data from a pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002588 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002617 | Genome and transcriptome sequence data from a small cell/neuroendocrine carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002630 | Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002601 | Genome and transcriptome sequence data from an invasive ductal carcinoma of left breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002606 | Genome and transcriptome sequence data from an adenocarcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002577 | Genome and transcriptome sequence data from an adenocarcinoma of primary unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002603 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002576 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002627 | Genome and transcriptome sequence data from an adenoid cystic carcinoma of the trachea patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002620 | Genome and transcriptome sequence data from a myxoid liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002645 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002632 | Genome and transcriptome sequence data from a testicular cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002634 | Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002582 | Genome and transcriptome sequence data from a squamous cell carcinoma of anal canal patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002600 | Genome and transcriptome sequence data from an adnexal tumor probable of Wolffian origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002560 | Genome and transcriptome sequence data from a cervical cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002610 | Genome and transcriptome sequence data from an invasive carcinoma of left breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002570 | Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002561 | Genome and transcriptome sequence data from a metastatic cervical cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002646 | Genome and transcriptome sequence data from an epithelioid mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002599 | Genome and transcriptome sequence data from a medullary thyroid carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002641 | Genome and transcriptome sequence data from a metastatic small cell carcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002586 | Genome and transcriptome sequence data from a squamous cell carcinoma of vulva patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002583 | Genome and transcriptome sequence data from a retroperitoneal leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002607 | Genome and transcriptome sequence data from a pancreatic cancer (likely PNET) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002635 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002590 | Genome and transcriptome sequence data from an adenomacarcinoma of vulva patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002625 | Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002587 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002572 | Genome and transcriptome sequence data from an infiltrating ductal carcinoma of right breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002619 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002571 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002614 | Genome and transcriptome sequence data from a thymic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002640 | Genome and transcriptome sequence data from a clival chordoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002643 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002574 | Genome and transcriptome sequence data from a ductal carcinoma of left breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002615 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002585 | Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002581 | Genome and transcriptome sequence data from a metastatic myxofibrosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002633 | Genome and transcriptome sequence data from an endometrial carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002612 | Genome and transcriptome sequence data from an esophageal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002644 | Genome and transcriptome sequence data from a multifocal hepatocellular carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002608 | Genome and transcriptome sequence data from a pleomorphic spindle cell sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002597 | Genome and transcriptome sequence data from a pancreatic ductal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002596 | Genome and transcriptome sequence data from a porocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002605 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002566 | Genome and transcriptome sequence data from a uveal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002594 | Genome and transcriptome sequence data from a peritoneal mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002591 | Genome and transcriptome sequence data from a neuroendocrine tumor likely pancreatic origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002624 | Genome and transcriptome sequence data from a squamous cell carcinoma of unknown primary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002618 | Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002616 | Genome and transcriptome sequence data from a superficial pleomorphic liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002578 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002629 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002626 | Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002595 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the GE junction patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002569 | Genome and transcriptome sequence data from a primary unknown cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002602 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002613 | Genome and transcriptome sequence data from a breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001001963 | Genome and transcriptome sequence data from a non small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002562 | Genome and transcriptome sequence data from an osteogenic sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002563 | Genome and transcriptome sequence data from a follicular lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | bam | |
| EGAD00001002907 | ATAC-seq data for 2 sample(s) for osteoclast from venous blood, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002901 | ATAC-seq data for 2 sample(s) for monocyte RPMI_LPS_T=24hrs_RPMI_T=5days from venous blood, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002908 | ATAC-seq data for 2 sample(s) for class switched memory B cell from venous blood, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002912 | ATAC-seq data for 2 sample(s) for plasma cell from tonsil, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002944 | ChIPmentation data for 2 sample(s) Activated B-Cell-Like Diffuse Large B-Cell Lymphoma from lymph node, on Genome GRCh38. 3 run(s), 3 experiment(s), 3 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002938 | ChIPmentation data for 2 sample(s) T-cell Acute Lymphocytic Leukemia from capillary blood, on Genome GRCh38. 2 run(s), 2 experiment(s), 2 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002924 | ChIPmentation data for 2 sample(s) for central memory CD8-positive, alpha-beta T cell from venous blood, on Genome GRCh38. 11 run(s), 7 experiment(s), 7 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002942 | ChIPmentation data for 2 sample(s) for regulatory T cell from venous blood, on Genome GRCh38. 14 run(s), 9 experiment(s), 9 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002946 | ChIPmentation data for 2 sample(s) Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma from lymph node, on Genome GRCh38. 6 run(s), 6 experiment(s), 6 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002935 | ChIPmentation data for 2 sample(s) Acute Myeloid Leukemia for blast cell from bone marrow, on Genome GRCh38. 12 run(s), 6 experiment(s), 6 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002923 | ChIPmentation data for 2 sample(s) for memory B cell from venous blood, on Genome GRCh38. 6 run(s), 4 experiment(s), 4 alignment(s). Part of BLUEPRINT (September 2016). | NextSeq 500;ILLUMINA | 2 | bam,fastq |
| EGAD00001002968 | RNA-Seq data for 2 sample(s) Acute Myeloid Leukemia for myeloid cell from venous blood, on Genome GRCh38. 2 run(s), 2 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 2 | fastq |
| EGAD00001002956 | RNA-Seq data for 2 sample(s) T-cell lymphoma for helper T cell from venous blood, on Genome GRCh38. 2 run(s), 2 experiment(s), 0 alignment(s). Part of BLUEPRINT (September 2016).Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000;ILLUMINA | 2 | fastq |
| EGAD00001003073 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the pancreas patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003078 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003006 | Genome and transcriptome sequence data from a metastatic medullary thyroid cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002993 | Genome and transcriptome sequence data from a metastatic carcinoma of primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003003 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002983 | Genome and transcriptome sequence data from a metastatic carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003023 | Genome and transcriptome sequence data from a metastatic renal cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003046 | Genome and transcriptome sequence data from a sigmoid cancer and an ampullary cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003070 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002977 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003048 | Genome and transcriptome sequence data from a metastatic pancreatic neuroendocrine tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002974 | Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003081 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003077 | Genome and transcriptome sequence data from a metastatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003024 | Genome and transcriptome sequence data from a liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003075 | Genome and transcriptome sequence data from a metastatic colon caner patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003065 | Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma of the palate patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003051 | Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002984 | Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002976 | Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003063 | Genome and transcriptome sequence data from an atypical bronchial carcinoid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003058 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003031 | Genome and transcriptome sequence data from a metastatic collecting duct kidney cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003016 | Genome and transcriptome sequence data from a metastatic ductal carcinoma of the breast patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003087 | Genome and transcriptome sequence data from a pancreatic neuroendocrine cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003037 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003035 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003012 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003066 | Genome and transcriptome sequence data from an appendiceal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003076 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003088 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002986 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002999 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003042 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002991 | Genome and transcriptome sequence data from a cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003014 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002981 | Genome and transcriptome sequence data from a metastatic pancreatic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003002 | Genome and transcriptome sequence data from a metastatic adult granulosa cell tumour patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002990 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003090 | Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003054 | Genome and transcriptome sequence data from a low-grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003022 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003000 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003044 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003028 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003013 | Genome and transcriptome sequence data from a metastatic gastric cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002996 | Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003011 | Genome and transcriptome sequence data from a squamous cell carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003005 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003001 | Genome and transcriptome sequence data from a serous carcinoma of fallopian tube patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003071 | Genome and transcriptome sequence data from a pleural mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003045 | Genome and transcriptome sequence data from a metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003082 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003033 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003015 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003009 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003060 | Genome and transcriptome sequence data from a liposarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003019 | Genome and transcriptome sequence data from a metastatic uveal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002979 | Genome and transcriptome sequence data from a GI primary (prev breast cancer) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003007 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003026 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003059 | Genome and transcriptome sequence data from a metastatic mullerian tumor of endometrium patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002980 | Genome and transcriptome sequence data from a metastatic fibrolamellar hepatocelluar carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003010 | Genome and transcriptome sequence data from a metastatic uterine leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003083 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002988 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003080 | Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003008 | Genome and transcriptome sequence data from a metastatic adenocarcinoma presumably of ovarian origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003021 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002972 | Genome and transcriptome sequence data from a breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003025 | Genome and transcriptome sequence data from an endometrial adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003020 | Genome and transcriptome sequence data from a low grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003056 | Genome and transcriptome sequence data from a solitary fibrous tumors (sarcoma) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002997 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003040 | Genome and transcriptome sequence data from a chordoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003055 | Genome and transcriptome sequence data from a small bowel carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003047 | Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003036 | Genome and transcriptome sequence data from an ovarian adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003030 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002975 | Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma of unknown primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003039 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002982 | Genome and transcriptome sequence data from a metastatic rectosigmoid adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003091 | Genome and transcriptome sequence data from a clear cell carcinoma of ovary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002987 | Genome and transcriptome sequence data from a metastatic endocervical adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003064 | Genome and transcriptome sequence data from an ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002998 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003041 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003017 | Genome and transcriptome sequence data from a metastatic large cell neuroendocrine tumour of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003068 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002985 | Genome and transcriptome sequence data from a adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003067 | Genome and transcriptome sequence data from a metastatic gastroesophageal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002995 | Genome and transcriptome sequence data from a carcinosarcoma of the uterus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003079 | Genome and transcriptome sequence data from a presumed metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003069 | Genome and transcriptome sequence data from a pancreatic neuroendocrine tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003052 | Genome and transcriptome sequence data from a metastatic malignant peripheral nerve sheath tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003018 | Genome and transcriptome sequence data from a metastatic clear cell sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003085 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002891 | Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003084 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003032 | Genome and transcriptome sequence data from a metastatic gastric adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003053 | Genome and transcriptome sequence data from an adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003072 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003061 | Genome and transcriptome sequence data from an adenocarcinoma of the distal esophagus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002978 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003043 | Genome and transcriptome sequence data from a breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003038 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003089 | Genome and transcriptome sequence data from a pancreatic neuroendocrine patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003004 | Genome and transcriptome sequence data from a glioblastoma multiforme patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003050 | Genome and transcriptome sequence data from a serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002083 | Whole-genome sequencing on Illumina HiSeq2000/2500 of normal colon control tissue | Illumina HiSeq 2000; | 2 | |
| EGAD00001002094 | Whole-exome sequencing on Illumina HiSeq2000/2500 of normal colon control tissue | Illumina HiSeq 2000; | 2 | |
| EGAD00001001967 | Genome and transcriptome sequence data from an adenocarcinoma of right lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002973 | Genome and transcriptome sequence data from a rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002992 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003086 | Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003057 | Genome and transcriptome sequence data from a metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003034 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002994 | Genome and transcriptome sequence data from a metastatic squamous cell carcinoma of anus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002989 | Genome and transcriptome sequence data from a medullary thyroid cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003074 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003027 | Genome and transcriptome sequence data from an anaplastic myxopapillary ependymoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003193 | Exome sequencing for 2 infertile brothers | Illumina HiSeq 2500;ILLUMINA | 2 | |
| EGAD00001003326 | Azoospermia, characterized by the absence of spermatozoa in the ejaculate is a common cause of male infertility with a poorly characterized etiology. Exome sequencing analysis of two azoospermic brothers allowed the identification of a homozygous splice mutation in SPINK2, encoding a serine protease inhibitor believed to target acrosin, the main sperm acrosomal protease. In accord with these findings we observed that homozygous Spink2 KO male mice had azoospermia. Moreover, despite normal fertility, heterozygous male mice had a high rate of morphologically abnormal spermatozoa and a reduced sperm motility. Further analysis demonstrated that in the absence of Spink2, protease-induced stress initiates Golgi fragmentation and prevents acrosome biogenesis leading to spermatid differentiation arrest. We also observed a deleterious effect of acrosin overexpression in HEK cells, effect that was alleviated by SPINK2 coexpression confirming its role as acrosin inhibitor. These results demonstrate that SPINK2 is necessary to neutralize proteases during their cellular transit towards the acrosome and that its deficiency induces a pathological continuum ranging from oligoasthenoteratozoospermia in heterozygotes to azoospermia in homozygotes. | Illumina HiSeq 2000;ILLUMINA | 2 | |
| EGAD00001003463 | These are the vcf files of exome sequencing of the two probands who were found to harbor mutations in KLB. Sample: EGAN00001564799 is the proband 1; Sample: EGAN00001564800 is the proband 11 in the KLB paper. Exome capture was performed using the SureSelect All Exon capture (Agilent Technologies, Santa Clara, CA USA) and sequenced on the HiSeq2500 (Illumina, San Diego CA USA). | 2 | ||
| EGAD00001003527 | HipSci - Retinitis Pigmentosa - Exome Sequencing - July 2017 | Illumina HiSeq 2500 (ILLUMINA) | 2 | |
| EGAD00001003542 | HipSci - Retinitis Pigmentosa - RNA Sequencing - July 2017 | Illumina HiSeq 2500 (ILLUMINA) | 2 | |
| EGAD00001003511 | BAM files with sequencing reads derived from Oxford Nanopore MinION whole genome sequencing of two DNA samples from lymphoblastoid cell lines from two patients with congenital disease. Samples were prepared using 1D and 2D library preps. | MinION;OXFORD_NANOPORE | 2 | |
| EGAD00001003510 | BAM files with sequencing reads derived from Illumina whole genome sequencing of two DNA samples from lymphoblastoid cell lines from two patients with congenital disease. Whole genome sequencing was performed using Illumina HiSeq X Ten and samples were prepared using TruSeq library prep. | HiSeq X Ten;ILLUMINA | 2 | |
| EGAD00001003429 | RNA analysis of two patients 11 and 15 with WGS done on Illumina HiSeq2000. For research purpose and authorised user only. | Illumina HiSeq 2000;ILLUMINA | 2 | |
| EGAD00001003750 | This is the first whole exome sequencing analysis of a primary meningeal melanocytic tumour (MMT) alongside the patients germline. Here we report the CRAM files from the tumour and germline. | Illumina HiSeq 2500;ILLUMINA | 2 | |
| EGAD00001003744 | Genome and transcriptome sequence data from a pleomorphic xanthoastrocytoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003712 | Genome and transcriptome sequence data from a primary of unknown origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003668 | Genome and transcriptome sequence data from a metastatic rhabdomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003680 | Genome and transcriptome sequence data from a low grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003666 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003709 | Genome and transcriptome sequence data from a high-grade serous fallopian tube carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003612 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003737 | Genome and transcriptome sequence data from a sinus adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003724 | Genome and transcriptome sequence data from a T-cell rich B cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003683 | Genome and transcriptome sequence data from a metastatic high grade sarcomatous neoplasm nos patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003667 | Genome and transcriptome sequence data from a metastatic gastrointestinal stromal tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003635 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003628 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of appendiceal origin patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003674 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003624 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003645 | Genome and transcriptome sequence data from an anaplastic ependymoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003639 | Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003643 | Genome and transcriptome sequence data from a metastatic cecal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003718 | Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003739 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003650 | Genome and transcriptome sequence data from a metastatic non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003653 | Genome and transcriptome sequence data from a non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003630 | Genome and transcriptome sequence data from a radiation-induced pleomorphic sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003670 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003615 | Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003713 | Genome and transcriptome sequence data from a low-grade serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003655 | Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003672 | Genome and transcriptome sequence data from a metastatic clear cell ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003686 | Genome and transcriptome sequence data from a metastatic neuroendocrine tumor arising from small bowel patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003743 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003682 | Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003687 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003660 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003642 | Genome and transcriptome sequence data from a metastatic neuroendocrine carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003616 | Genome and transcriptome sequence data from an adenocarcimona of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003652 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003734 | Genome and transcriptome sequence data from a spindle cell carcinoma of the left parotid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003725 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectosigmoid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003647 | Genome and transcriptome sequence data from an anal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003604 | Genome and transcriptome sequence data from a metastatic gallbladder cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003619 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003685 | Genome and transcriptome sequence data from an osterosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003692 | Genome and transcriptome sequence data from a metastatic gastrointestinal stromal tumour patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003684 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003658 | Genome and transcriptome sequence data from a primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003736 | Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003679 | Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003700 | Genome and transcriptome sequence data from a thymic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003694 | Genome and transcriptome sequence data from a pleomorphic sarcomatoid epithelioid carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003608 | Genome and transcriptome sequence data from a metastatic small cell carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003730 | Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003664 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003699 | Genome and transcriptome sequence data from a metastatic lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003625 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003675 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003741 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003733 | Genome and transcriptome sequence data from a metastatic uterine leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003631 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003614 | Genome and transcriptome sequence data from a metastatic non-small cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003665 | Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003623 | Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003716 | Genome and transcriptome sequence data from a melanoma of the right buccal mucosa patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003702 | Genome and transcriptome sequence data from a high grade serous carcinoma of the fallopian tube/ovary/peritoneum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003657 | Genome and transcriptome sequence data from an adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003726 | Genome and transcriptome sequence data from a large-cell neuroendocrine lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003609 | Genome and transcriptome sequence data from a metastatic serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003610 | Genome and transcriptome sequence data from a mullerian mixed tumor with carcinosarcoma of the ovaries patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003696 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003640 | Genome and transcriptome sequence data from a metastatic adenoid cystic carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003606 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the rectum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003731 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003656 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003723 | Genome and transcriptome sequence data from a squamous cell carcinoma of the anus patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003717 | Genome and transcriptome sequence data from a metastatic non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003710 | Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003662 | Genome and transcriptome sequence data from a left cavernous sinus invasive skull meningioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003641 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003708 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003673 | Genome and transcriptome sequence data from a metastatic adenocarcinoma of the ge junction patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003644 | Genome and transcriptome sequence data from a metastatic spindle cell sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003632 | Genome and transcriptome sequence data from a chronic lymphocytic leukemia patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003728 | Genome and transcriptome sequence data from a metastatic gastrointestinal stromal tumor patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003693 | Genome and transcriptome sequence data from a metastatic rectal adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003721 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003621 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003629 | Genome and transcriptome sequence data from a metastatic gastric cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003638 | Genome and transcriptome sequence data from a metastatic prostate cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003626 | Genome and transcriptome sequence data from a retroperitoneal mucinous cystic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003636 | Genome and transcriptome sequence data from a metastatic paraganglioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003732 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003678 | Genome and transcriptome sequence data from a thymoma carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003698 | Genome and transcriptome sequence data from a locally advanced right breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003681 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003714 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003659 | Genome and transcriptome sequence data from an ependymoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003715 | Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003729 | Genome and transcriptome sequence data from a peripheral T-cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003742 | Genome and transcriptome sequence data from an adenocarcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003648 | Genome and transcriptome sequence data from a glioblastoma multiforme patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003613 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003637 | Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003720 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003620 | Genome and transcriptome sequence data from a metastatic colorectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003688 | Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003607 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003695 | Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003605 | Genome and transcriptome sequence data from a metastatic colonic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003719 | Genome and transcriptome sequence data from a metastatic breast carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003617 | Genome and transcriptome sequence data from a non-small cell lung cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003646 | Genome and transcriptome sequence data from a squamous cell carcinoma of ge junction patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003633 | Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003722 | Genome and transcriptome sequence data from a primary unknown patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003738 | Genome and transcriptome sequence data from a Ewing sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003627 | Genome and transcriptome sequence data from a salivary duct carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003740 | Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003677 | Genome and transcriptome sequence data from a metastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003701 | Genome and transcriptome sequence data from a metastatic myoepithelial carcinoma of parotid patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003611 | Genome and transcriptome sequence data from a metastatic cecal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003651 | Genome and transcriptome sequence data from a metastatic colon adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003669 | Genome and transcriptome sequence data from a metastatic mucinous adenocarcinoma of the rectum patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003622 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003711 | Genome and transcriptome sequence data from a bilateral breast lobular cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003697 | Genome and transcriptome sequence data from a metastatic meningioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003649 | Genome and transcriptome sequence data from a metastatic colon adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003663 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003676 | Genome and transcriptome sequence data from a metastatic adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003735 | Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003634 | Genome and transcriptome sequence data from a solitary fibrous tumors (sarcoma) patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003654 | Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003603 | Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003661 | Genome and transcriptome sequence data from an advanced adenocarcinoma of lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003689 | Genome and transcriptome sequence data from a metastatic epitheloid angiomyelolipoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003727 | Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003691 | Genome sequence data from a metastatic squamous cell carcinoma of the oropharynx patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001003618 | Genome and transcriptome sequence data from a mesothelioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study | 2 | ||
| EGAD00001002264 | This data set consists of whole genome SMRT sequencing fastqs generated from 2 xenograft samples. | PacBio RS II; | 2 | |
| EGAD00001003953 | Fastq files for the whole genome sequencing data (Illumina HiSeq 2500; 32.6-fold) for two diffuse gastric cancers revealing the fusion breakpoints. 2102T: CTNND1-ARHGAP26 gene fusion (g.chr11:57,578,103-g.chr5:142,358,707) 354T: ANXA2-MYO9A gene fusion (g.chr15:60,656,550-g.chr15:72,157,966) | Illumina HiSeq 2500;ILLUMINA | 2 | |
| EGAD00001003955 | This dataset comprises single-cell RNA sequencing of the human Lin-CD34+38-45RA-90+49f+ phenotype isolated from 2 normal cord donors. Library preparation was performed following a modified CEL-Seq2 protocol. | NextSeq 500;ILLUMINA | 2 | |
| EGAD00001003323 | Runs that contain data for the sensitivity and specificity experiments for BiSeqS. | Illumina MiSeq;ILLUMINA | 2 | |
| EGAD00001003325 | Exome from EGAS00001002441 | Illumina HiSeq 2500;ILLUMINA | 2 | |
| EGAD00001000444 | Cancer is driven my mutations in the genome. We will uncover the mutations that give rise to Ewing's sarcoma, a bone tumour that largely affects children. We will use second generation Illumina massively parallel sequencing, and bespoke software, to characterise the genomes and transcriptomes of Ewing's sarcoma tumours. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000034 | "Usage of small amounts of DNA for Illumina sequencing" | Illumina Genome Analyzer II | 3 | bam |
| EGAD00001000090 | Glioma cell lines rearrangement screen | Illumina Genome Analyzer II | 3 | bam |
| EGAD00001000381 | Illumina paired-end sequencing of whole- exome pulldown DNA from Severe Insulin Resistant patients. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000220 | Deep sequencing of CTCs | 454 GS FLX Titanium;, Illumina MiSeq; | 3 | bam |
| EGAD00001000340 | The objective of this study is to resequence of targeted intervals containing autosomal recessive variants causing neurological disorders in consanguineous pedigrees. Using homozygosity mapping, three intervals of very different sizes have previously been unambiguously mapped for three different neurological diseases: 2.4Mb, 8Mb and 14.3Mb in size, for Microlissencephaly, Severe Mental Retardation and Complicated hereditary spastic paraplegia respectively. This study is a pilot to assess how well custom targeted resequencing performs across a broad size range of intervals. The study design is to use a different custom capture probe set for each interval, pulldown from a single patient from each family, and sequence 1 lane using Illumina paired-reads for each sample. Candidate variants will be followed up in the families themselves, and in patients with similar phenotypes from outbred populations | Illumina Genome Analyzer II; | 3 | bam |
| EGAD00001000060 | Acral melanoma study whole genomes | Complete Genomics | 3 | CompleteGenomics_native |
| EGAD00001000061 | Acral melanoma study whole exomes | Illumina Genome Analyzer IIx | 3 | fastq |
| EGAD00001000369 | We propose to definitively characterise the somatic genetics of a number of pediatric malignant tumours including ependymoma, high grade glioma and central nervous system primitive neurectodermal tumours through generation of comprehensive catalogues of somatic mutations by high coverage genome sequencing. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000361 | This is a small pilot data set to test the feasibility of cDNA exomes across 1200 cancer cell line panel. cDNA exomes or Fus-seq is further explained in this studies Abstract. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000368 | Genomic libraries (500 bps) will be generated from total genomic DNA derived from Osteosarcoma cancer patients and subjected to short paired end sequencing on the llumina platform. Paired reads will be mapped to build 37 of the human reference genome to facilitate the generation of genome wide copy number information, and the identification of novel rearranged cancer genes and gene fusions. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000338 | We propose to definitively characterise the somatic genetics of ER+ve, HER2-ve breast cancer through generation of comprehensive catalogues of somatic mutations in breast cancer cases by high coverage genome sequencing coupled with integrated transcriptomic and methylation analyses. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000639 | Insertion of processed pseudogenes is known to occur in the germline but has not previously been observed in somatic cells. Formation of pseudogenes could represent a new class of mutation in cancers and a new source of potential driver events. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000672 | Whole-genome Bisulfite sequencing of two multiple myeloma samples and one pooled sample of plasma cells. | Illumina HiSeq 2000; | 3 | bam |
| EGAD00001000732 | RNA sequencing to validate findings of somatic pseudogenes acquired during cancer development | Illumina HiSeq 2000; | 3 | cram |
| EGAD00001000908 | RNA-Seq data for 3 inflammatory macrophage sample(s). 3 run(s), 3 experiment(s), 3 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 3 | fastq |
| EGAD00001000925 | ChIP-Seq data for 3 CD4-positive, alpha-beta T cell sample(s). 21 run(s), 21 experiment(s), 21 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 3 | fastq |
| EGAD00001000940 | ChIP-Seq data for 3 inflammatory macrophage sample(s). 21 run(s), 21 experiment(s), 21 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_chipseq_analysis_ebi_20140811 | Illumina HiSeq 2000; | 3 | fastq |
| EGAD00001000914 | Bisulfite-Seq data for 3 inflammatory macrophage sample(s). 38 run(s), 3 experiment(s), 3 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_bisulphite_analysis_CNAG_20140811 | Illumina HiSeq 2000; | 3 | bam,readme_file |
| EGAD00001000919 | RNA-Seq data for 3 hematopoietic multipotent progenitor cell sample(s). 9 run(s), 3 experiment(s), 3 alignment(s). Part of BLUEPRINT release August 2014. Analysis documentation available at http://ftp.ebi.ac.uk/pub/databases/blueprint/releases/20140811/homo_sapiens/README_rnaseq_analysis_crg_20140811 | Illumina HiSeq 2000; | 3 |